Regulation of Growth by Drosophila FoxO Transcription Factor by Mattila, Jaakko
9/2009 9/2009
JA
A
K
KO
 M
A
TTILA
  R
egulation of G
row
th by D
rosophila FO
X
O
 Transcription Factor
Regulation of Growth by Drosophila FOXO 
Transcription Factor
Dissertationes bioscientiarum molecularium Universitatis Helsingiensis in Viikki
JAAKKO MATTILA
Institute of Biotechnology 
and 
Division of Genetics
Department of Biological and Environmental Sciences
Faculty of Biosciences
and
Helsinki Graduate School in Biotechnology and Molecular Biology
University of Helsinki
Recent Publications in this Series:
37/2008 Anne Tammimäki
Roles of Forced Nicotine Exposure and Comt Gene Disruption in the Development of Addiction-Related 
Behavioural and Neurochemical Changes in Mice
38/2008 Jaakko Pakarinen
Impact of the Human Bacterial Environment on Mycobacteriosis and Allergy
39/2008 Peter Würtz
Aspects and Applications of Pulse Sequence Design for Solution-State Nuclear Magnetic Resonance Spectroscopy
40/2008 Tanja Lipsanen
Process Analytical Technology Approach on Fluid Bed Granulation and Drying - Identifying Critical 
Relationships and Constructing the Design Space
41/2008 Gabija Žiedaitė
DNA Packaging and Host Cell Lysis: Late Events in Bacteriophage PRD1 Infection
42/2008 Susanna Nurmi
LFA-1 Integrin β2 Chain Phosphorylation Regulates Protein Interactions and Mediates Signals in T Cells
43/2008 Anastasia Ludwig
Mechanisms of KCC2 Upregulation During Development
44/2008 Camelia Constantin
Cereulide Producing B. Cereus and Amylosin Producing B. Subtilis and B. Mojavensis: Characterization of 
Strains and Toxigenicities
45/2008 Eva Ruusuvuori
Ion-Regulatory Proteins in Neuronal Development and Communication
46/2008 Katrianna Halinen
Genetic Diversity and Microcystin Production by Anabaena in the Gulf of Finland, Baltic Sea
47/2008 Mikhail Paveliev
Co-Signaling by Neurotrophic Factors and the Extracellular Matrix for Axonal Growth and Neuronal Survival
48/2008 Keyvan Dastmalchi
Dracocephalum moldavica L. and Melissa offi cinalis L.: Chemistry and Bioactivities Relevant in Alzheimer’s 
Disease Therapy
49/2008 Laura Mattinen
Expression Analysis of Host-Induced Genes and Proteins of Potato Pathogen Pectobacterium atrosepticum
50/2008 Anna Galkin
Evaluation of Natural Products in Apoptosis, Protein Kinase C Activation and Caco-2 Cell Permeability
1/2009 Petra Kukkaro
Characterization of New Viruses from Hypersaline Environments
2/2009 Elisa Nevalainen
The Biological Functions of Mouse Twinfi lin Isoforms
3/2009  Anne-Sisko Patana
The Human UDP-Glucuronosyltransferases: Studies on Substrate Binding and Catalytic Mechanism
4/2009 Tanja Kivinummi
Effects of Chronic Nicotine on Behavioural and Neurochemical Responses to Morphine
5/2009 Ville Kaila
Theoretical Studies on Coupled Electron and Proton Transfer in Cytochrome c Oxidase
6/2009 Li-ying Yu
Death Pathways Activated in the Neurotrophic Factor-Deprived Neurons
7/2009 Timo Hytönen
Regulation of Strawberry Growth and Development
8/2009 Paula Lehto
Mechanistic Studies of Drug Dissolution Testing. Implications of Solid Phase Properties and in vivo Prognostic 
Media
Helsinki 2009         ISSN 1795-7079   ISBN 978-952-10-5364-1
REGULATION OF GROWTH BY DROSOPHILA 
FOXO TRANSCRIPTION FACTOR
Jaakko Mattila
Institute of Biotechnology
Division of Genetics
Department of Biological and Environmental Sciences
Faculty of Biosciences
University of Helsinki
And
Helsinki Graduate School in Biotechnology and Molecular Biology
Academic Dissertation
To be publicly discussed, with the permission of the Faculty of Biosciences, University 
of Helsinki, in the auditorium 2 of the Infocenter Korona, Viikinkaari 11, Helsinki, on 
April 17th, 2009, at 12 o’clock noon.
Helsinki 2009
Supervisor  Docent Oscar Puig
   Institute of Biotechnology
   University of Helsinki, Finland
Reviewers  Professor Pekka Lappalainen
   Institute of Biotechnology
   University of Helsinki, Finland
   Docent Jukka Westermarck
   Institute of Medical Technology
   University of Tampere, Finland
Opponent  Professor Pierre Leopold
   Institute of Developmental Biology and Cancer,  
   CNRS
   University of Nice, France
ISSN 1795-7079
ISBN 978-952-10-5364-1
ISBN  978-952-10-5365-8 (PDF)
Helsinki 2009, Helsinki University Printing House
Jos olemme viisaita, 
meidän on erittäin kriitillisesti tutkittava varsinkin niitä käsityksiämme, 
joiden epäileminen tuottaa meille suurinta tuskaa.
Bertrand Russell
CONTENTS
LIST OF ORIGINAL PUBLICATIONS
ABBREVIATIONS
ABSTRACT
INTRODUCTION .........................................................................................................1
REVIEW OF THE LITERATURE ..............................................................................3
 Cellular signaling ....................................................................................................3
  Signaling pathway components .........................................................................3
 Cellular signaling regulating growth and metabolism ........................................5
  Insulin signaling ................................................................................................5
  Cyclic adenosine monophosphate signaling pathway .......................................6
  Protein kinase C signaling .................................................................................8
 Forkhead box class “O” transcription factors .....................................................9
  Short historic perspective ................................................................................10
  Molecular function, structure and conservation of FoxO proteins ..................11
 Regulation of FoxO activity .................................................................................12
  Regulation of FoxO by Akt .............................................................................13
  Regulatory network around FoxO ...................................................................13
 Biological functions of FoxO ................................................................................18
  Cell differentiation ...........................................................................................18
  Growth  ...........................................................................................................19
  Cell cycle .........................................................................................................21
  Energy metabolism ..........................................................................................22
  Life span ..........................................................................................................23
AIMS OF THE STUDY ...............................................................................................25
MATERIALS AND METHODS .................................................................................26
  Cell culture (I, II, III) .......................................................................................26
  Luciferase assay (I, II, III) ...............................................................................26
  RNA interference (II, III) ................................................................................26
  Band shift assay (I, III) ....................................................................................27
  Cyclic AMP measurement (III) .......................................................................27
  Quantitative RT-PCR (I, II, III) .......................................................................27
  High throughput microscopy (II) .....................................................................27
  Transgenic animals (III) ..................................................................................27
  RNA in situ hybridization (III) ........................................................................27
  Antibodies used for western blotting (II, III) ..................................................28
RESULTS  .....................................................................................................................29
 dFoxO induces the expression of scylla and astray (I) .......................................29
 Regulatory network around FoxO (II) ...............................................................29
 FoxO is a regulator of cAMP signaling in Drosophila (III) ...............................31
 dFoxO regulates Drosophila development, size and 
 starvation resistance through Adenylate cyclase 76E (III) ...............................31
DISCUSSION  ...........................................................................................................32
 FoxO is a conditional, Insulin/TOR signaling dependent regulator of 
 tissue growth (I) ....................................................................................................32
 FoxO activity is modulated by an elaborate regulatory network (II) ..............33
 Systemic regulation of development and size by dFoxO 
 through AC76E (III) .............................................................................................35
CONCLUSIONS ..........................................................................................................37
FUTURE PROSPECTS...............................................................................................38
ACKNOWLEDGEMENTS ........................................................................................39
REFERENCES  ...........................................................................................................40
LIST OF ORIGINAL PUBLICATIONS
This thesis is based on the following original publications and unpublished data, which 
are referred to in the text by their Roman numerals I-III.
I Harvey KF, Mattila J, Sofer A, Bennett FC, Ramsey MR, Ellisen LW, Puig O, 
Hariharan IK. FoxO-regulated transcription restricts overgrowth of Tsc mutant 
organs. J Cell Biol. 2008 Feb;180(4):691-696
II  Mattila J, Kallijärvi J, Puig O. RNAi screening for kinases and phosphatases 
identifies FoxO regulators. Proc Natl Acad Sci USA. Sep;105(39):14873-
14878
III  Mattila J, Bremer A, Puig O. Drosophila FoxO regulates organism size and stress 
resistance through an Adenylate cyclase. (submitted)

ABBREVIATIONS
4EBP  eIF4E binding protein
AC  Adenylate cyclase
AKH  Adipokinetic hormone
Akt  Protein kinase B
AMP  Adenosine monophosphate
AMPK  Adenosine monophosphate activated kinase
ATP  Adenosine triphosphate
CA  Corpus allatum
cAMP  Cyclic adenosine monophosphate
CC  Corpora cardiaca
CDK2  Cyclin dependent kinase 2
cGMP  Cyclic guanoside monophosphate
CGKI  Cyclic guanosine monophosphate regulated kinase I
CK1  Casein kinase 1
CREB  cAMP-response-element-binding protein
DAF-2/16 Abnormal dauer formation 2/16
DILP  Drosophila Insulin-like peptide
DR  Dietary restriction
DSB  Double strand break
DYRK1 Dual-specifi city tyrosine-phosphorylated and regulated kinase 1
eIF4E  Eukaryotic Initiation factor 4E
FoxO  Forkhead box class “O”
FRE  FoxO recognition element
G6PASE Glucose-6-phosphatase
GSK3β  Glucose and serum regulated kinase 3β
IGF  Insulin-like growth factor
IKKβ  Ikappaβ kinase
INR  Insulin receptor
IPC  Insulin producing cell
IRS-1  Insulin receptor substrate 1
JNK  Jun N-terminal Kinase
MAPK  Mitogen activated protein kinase
MST-1  Mammalian sterile 20-like kinase-1
NLS  Nuclear localization signal
NES  Nuclear export signal
PDE  Phosphodiesterase
PDK1  Phosphoinositide-dependent kinase 1
PEPCK  Phosphoenolpyruvate carboxykinase
PH  Plecstrin homology domain
PI3K  Phosphatidylinositol 3’ –kinase
PIP2/3  phosphatidylinositol phosphate
PKA  Protein kinase A
PKB  Protein kinase B
PKC  Protein kinase C
PP2A  Protein phosphatase 2A
PTEN  Phosphatase with tensin homology
ROS  Reactive oxygen species
SER  Serine
SGK  Serum and glucocorticoid inducible kinase
TF  Transcription factor
TFIIB  Transcription factor IIB
TGF-β  Transforming growth factor β
THR  Threonine
TOR  Target of rapamycin
TORC  Transducer of regulated CREB activity
TORC1/2 Target of rapamycin complex 1/2
TSC1/2  Tuberous sclerosis complex 1/2
UV  Ultraviolet
ABSTRACT
Forkhead box class “O” (FoxO) transcription factors are members of the forkhead box 
transcription factor superfamily, with orthologues in various species such as human, 
worm and fl y. FoxO proteins are key regulators of growth, metabolism, stress resistance 
and, consequently, life span. FoxOs integrate signals from different pathways, e.g. the 
growth controlling Insulin-TOR signaling pathway and the stress induced JNK and 
Hippo signaling pathways. FoxO proteins have evolved to guide the cellular response to 
varying energy and stress conditions by inducing the expression of genes involved in the 
regulation of growth and metabolism. This work has aimed to deepen the understanding 
of how FoxO executes its biological functions. A particular emphasis has been laid 
to its role in growth control. Specifi cally, evidence is presented indicating that FoxO 
restricts tissue growth in a situation when TOR signaling is high. This fi nding can have 
implications in a human condition called Tuberous sclerosis, manifested by multiple 
benign tumors. Further, it is shown that FoxO directly binds to the promoter and regulates 
the expression of a Drosophila Adenylate cyclase gene, ac76e, which in turn modulates 
the fl y’s development and growth systemically. These results strengthen FoxOs position 
among central size regulators as it is able to operate at the level of individual cells as well 
as in the whole organism. Finally, an attempt to reveal the regulatory network upstream 
of FoxO has been carried out. Several putative FoxO activity regulators were identifi ed 
in an RNAi screen of Drosophila kinases and phosphatases. The results underscore that 
FoxO is regulated through an elaborate network, ensuring the correct execution of key 
cellular processes in metabolism and response to stress. Overall, the evidence provided 
in this study strengthens our view of FoxO as a key integrator of growth and stress 
signals.
1INTRODUCTION
Shortly after their discovery and characterization as transcription factors it became 
clear that FoxO proteins possess functions of exceptional interest in regard to organism 
well being. Consequently, FoxO mediated cellular processes have drawn a great deal of 
attention among researchers and after some fi fteen years of intense investigation, it is 
now known that FoxOs are a family of conserved multifunctional transducers of various 
growth and stress signals having implications in devastating diseases such as cancer 
and diabetes. Due to the combined effort from research in different model organisms it 
has become evident that FoxO proteins hold key roles in regulating processes such as 
growth (Junger et al. 2003, Puig et al. 2003), energy homeostasis (Zhang et al. 2006), 
protection from DNA-damage (Huang et al. 2006), cell cycle (Alvarez et al. 2001), 
cellular differentiation (Bois & Grosveld 2003) and life span (Hwangbo et al. 2004, 
Giannakou et al. 2004). It is the wide range of biological functions that has made FoxO 
particularly attractive as well as a challenging research object.
Growth is a fundamental biological process regulated through various means. FoxO 
proteins are known to exert their growth regulatory function by participating in the well 
conserved nutritional perception machinery regulated by the Insulin-Glucagon axis. 
Their role in this process is to mediate responses to energy deprivation. In mammals, 
upon hypoglycemia and subsequent attenuation of circulating Insulin, hepatic FoxO1 
is localized in the nucleus where it activates a pattern of gene expression devoted to 
gluconeogenesis and lipid catabolism (Zhang et al. 2006). This mechanism, among 
others, ensures the sustaining of correct blood glucose level and, consequently, cell 
growth. On the other hand, FoxO has a well defi ned role in slowing down growth in 
the peripheral tissues, i.e. muscle and adipose tissue, as a transducer of the Insulin/TOR 
signaling pathway (Brunet et al. 1999). For example, upon fasting FoxO is activated 
and induces expression of genes such as p27kip1 and p21cip1 which inhibit the cell 
cycle progress (Medema et al. 2000, Seoane et al. 2004). Hence, FoxO is acting in a 
cell autonomous and non-autonomous manner in adapting growth to the prevailing 
nutritional condition. The action of FoxO is therefore closely linked to the complex 
system of growth and metabolism and the understanding of these processes is pivotal in 
prevention and curing associated diseases such as diabetes and cancer.
Mechanisms behind FoxO regulated processes can be understood by functional 
analysis of its target genes. For example, the role of FoxO in stress resistance and 
life span regulation (Giannakou et al. 2004, Hwangbo et al. 2004, Wang et al. 2005), 
is achieved by ordered spatiotemporal activation of specifi c gene expression targets. 
Essential to understanding the regulation of these processes is to uncover which of the 
FoxO targets are involved and in which tissue the regulation takes place. For instance, 
a systems biology approach was recently applied to demonstrate the key role that FoxO 
holds in shifting the gene expression pattern upon changes in energy balance (Gershman 
et al. 2007). Whereas the role of some of the target genes is obvious, such as enzymes 
devoted to gluconeogenesis, a number of target genes still possess unknown functions. 
Hence, a more specifi c analysis of the target gene biology is needed to complement the 
fi ndings of the system biology approach and to understand FoxO biology in detail.
Introduction
2Given the interesting range of cellular and physiological processes where FoxO 
participates, particular interest has been addressed to its upstream regulatory factors. To 
date, several signaling pathways are known to act through FoxO transcription factors, 
regulating their stability, intracellular localization and transactivation property, and the 
number of new regulators is rapidly increasing (Huang & Tindall 2007). The general 
opinion is that FoxO is inhibited by growth factor-induced phosphorylation and nuclear 
exclusion (Brunet et al. 1999). However, further studies have demonstrated this to be 
a simplifi ed view since its transcriptional activity can be modulated with or without 
growth factors (Alvarez et al. 2001, Luong et al. 2006). It is therefore likely that our 
knowledge of the regulatory network around FoxO is still limited. At present, there has 
not been any report of a systemic screen aiming to fi nd novel FoxO modulators.
This work has focused on the role of FoxO in growth control. Evidence is presented 
increasing our knowledge of how FoxO regulates growth at the level of an individual 
cell and the whole organism. In summary, we demonstrate that FoxO induces the 
expression of a negative growth regulator scylla/redd1 upon an elevated TOR signaling 
pathway, presumably protecting tissues from overproliferation. Further, we establish 
the role of a novel Drosophila FoxO target, adenylate cyclase 76e, in systemic growth 
regulation. These results provide insights into how FoxO exerts its growth regulatory 
function. Finally, through an RNAi-based screen we show that FoxO is regulated by a 
complex network of kinases, which allows for an exquisitely balanced transcriptional 
activity necessary to adjust metabolic and growth responses to the prevailing nutritional 
conditions. Overall, our results underscore the complexity of processes regulated by 
FoxO transcription factors, which reflects their primary role, the coordination of 
organism growth in response to the nutrient availability and stress.
Introduction
3REVIEW OF THE LITERATURE
Cellular signaling
In order to survive, an organism needs to react to an alternating environment and adjust 
its behaviour to meet the prevailing conditions. The reaction of a metazoan animal is 
a result of a perception event which is followed by a coordinated response of various 
specialized cell types. This response ultimately leads to a change in animal behaviour. 
This coordinated action of metazoan operations relies on communication between cells. 
Hence, individual cells are faced with the same requirements as the organism as a whole: 
they need to receive information and respond in an appropriate manner. For the purpose 
of cellular communication, cells have evolved signaling mechanisms, depending on 
protein-protein interaction, to elicit and receive information (Bhattachayya et al. 2006). 
These mechanisms, i.e. cellular signaling pathways, collect and integrate information 
about extracellular conditions important for survival, growth and differentiation. 
By collecting information from its external milieu a cell is able to respond to changes 
in hormone, nutrient and growth factor composition and abundance by modulating its 
protein post-translational modifi cations and, ultimately, its transcriptional profi le. These 
alterations can lead to responses such as regulation of metabolism (Marshall 2006), cell 
differentiation (Pires-Da Silva & Sommer 2003), cell division (Jones & Kazlauskas 
2001), cell death (Jin & El-Deiry 2005), modulation of cellular cytoskeleton (Sinha & 
Yang 2008), cell movements (Condeelis et al. 2001, Guvakova 2007) and changes in 
action potential (Barnett & Larkman 2007). The response of a given cell to a given 
signal is dictated by its competence, i.e. the repertoire of molecular signal transduction 
mechanisms. These mechanisms, which refl ect the cells developmental history, consist 
of cell surface or intracellular receptors, intracellular signaling pathway components, 
transcription factors and other co-factors. The concept of competence explains why a 
given signal might result in different responses, depending on the cell type it stimulates. 
In addition, the outcome of a signaling event is also dependent on its strength and 
duration (Pawson & Nash 2001).
Core components of a classical signaling cascade are a ligand and its cognate 
receptor positioned either in the cell membrane or within a cell for small membrane 
permeable ligands. In its simplest form, a ligand is able to modify gene expression 
directly by binding to its receptor which in turn functions as a transcription factor. Such 
signaling is known to occur for many lipophilic steroid hormones such as estrogen and 
progesterone (Levin 2008). However, a number of more elegant systems consisting 
of several intracellular transducer and effector molecules have evolved in metazoans 
to allow a refi ned regulation of signal transduction. Common features in these signal 
transduction pathways are (1) specific protein-protein interactions which transmit 
the signal to one direction, (2) signal amplifi cation, (3) signal diversifi cation and/or 
integration and (4) multiple points of control (Weng et al. 1999, Pawson & Nash 2001).
Signaling pathway components
Signaling molecules, i.e. ligands, can vary from single ions to large multi-protein 
complexes. Roughly, ligands can be classifi ed as either cell-membrane permeable or 
non-permeable. The former includes lipid soluble cholesterol, tyrosine and vitamin 
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4A derivatives also known as steroid hormones, thyroid hormones and retinoids, 
respectively (Cheskis 2004, Zhang et al. 2000, Fields et al. 2007). Due to the insolubility 
to the aqueous environment, these ligands can not diffuse freely within a cell and are 
therefore attached to soluble carrier proteins (Schroeder et al. 2007). Ligands which can 
not penetrate passively through the cell membrane include ions (K+, Na+, Ca2+ and Cl-), 
organic compounds such as glycine and acetylcholine, nucleotide derivatives such as 
cAMP and cGMP, and fi nally, the large group of peptides and proteins. The heterogeneous 
group of protein ligands include growth factor families, for example Insulin-like 
growth factors and the Transforming growth factor β family (TGF-β) (Grimberg & 
Cohen 2000, Massague 2000). The action of the soluble ligands is transmitted through 
the cell membrane by specifi c ligand gated ion channels or transmembrane receptors. 
Transmembrane receptors, such as Receptor tyrosine kinases (Hubbard & Miller 2007), 
possess intrinsic enzymatic activity in their intracellular catalytic domain. The ligand-
receptor interaction triggers an excitatory signal elicited by the enzymatic activity of this 
catalytic domain. Alternatively, receptors are coupled with proteins possessing enzymatic 
activity (Shindler et al. 2007). Another, large group of receptors is the G-protein coupled 
receptors which transmit the signal through G-proteins, enzymes with GTPase activity 
(Oldham & Hamm 2008). Whatever the exact mode of action, a common theme is that 
the binding of a ligand to the extracellular domain of a transmembrane-receptor triggers 
the production/recruitment of signaling molecules, i.e. second messengers and signaling 
proteins, into the plasma membrane where an excitatory activity takes place. As a result, 
the signal is carried onward within the cell.
A signaling pathway can consist of several intracellular transducers. These are 
typically kinases and phosphatases which by incorporating or removing a phosphate 
group alter the physiochemical properties of a substrate protein or a second messenger 
such as inositol-lipids (Daves & Krebs 1999, Vanhaesebroeck et al. 2001). A signaling 
pathway may consist of several kinases which sequentially phosphorylate each other in 
a specifi ed order. Classical examples are the mitogen activated protein kinase (MAPK) 
signaling pathways, having at least three sequentially activated protein kinases (Pimienta 
& Pascual 2007). A characteristic consequence of a protein phosphorylation event is a 
conformational change in its three dimensional structure, which exposes its catalytic 
cleft to interact with its substrates (Shi et al. 2006). Good examples of such an allosteric 
regulation are the activation of the ABC kinase family members Protein kinase C (PKC) 
and Protein kinase B (PKB/Akt) (Dutil & Newton 2000, Calleja et al. 2007). In addition 
to kinases and phosphatases a signaling pathway may contain several other adapter 
proteins which may facilitate protein-protein interactions and enzymatic activity (Pratt et 
al. 2008).  For example, Akt is known to associate with more then ten different proteins 
having roles in its stabilization, kinase activity and intracellular transport (Du & Tsichlis 
2005). 
Most, if not all, signaling events result in changes in the transcriptional activity of 
the cell. These changes are mediated by inducible transcription factors (TF) which are 
sequence specifi c DNA binding factors regulating the initiation of gene expression. TFs 
bind to the so called response elements, i.e. short consensus DNA sequences, with their 
DNA binding domain and facilitate the initiation of transcription by directly contacting 
and stabilizing the basal transcription apparatus (Becket 2001, Marmorstein & Fitzgerald 
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52002). TFs are grouped into super-families based on their DNA binding domains. These 
include, for example, the helix-turn-helix or the leucine zipper domain (Pabo & Sauer 
1992). Finally, the activity of TFs is modulated by a heterogeneous group of co-factors 
which by themselves do not bind to DNA, but regulate the TF-DNA complex stability 
(Featherstone 2002).
Cellular signaling regulating growth and metabolism
One of the major, still incompletely understood problems in biology is how the fi nal 
size and organ proportions of an organism are achieved (Mirth & Riddiford 2007). The 
highly ordered and synchronized tissue growth requires crosstalk between the animal’s 
energy sensing/producing and energy consuming tissues. Many signaling pathways are 
involved in this communication. These include MAPK, TGF-β, Insulin/TOR, cAMP and 
PKC signaling. Below are briefl y introduced central signaling systems involved in the 
regulation of growth and metabolism important for this work.
Insulin signaling
Important solution for systemic growth regulation in metazoan organisms are Insulin and 
an Insulin like growth factor (IGF) which have evolved to be regulators of metabolism 
and growth, respectively (Oldham & Hafen 2003). These signaling molecules transmit 
nutritional information to cells and guide their growth and division rate to meet the 
environmental conditions. Proper functioning of the Insulin signaling pathway is pivotal 
to organism homeostasis and failure to regulate its activity can lead to diseases such as 
diabetes and cancer (Vivanco & Sawyers 2002). 
Insulin binding to its cognate receptor leads to an ordered, well defi ned cascade of 
signaling molecule interactions (Figure 1). Briefl y, activation of the Insulin receptor (InR) 
by ligand binding is followed by the production of a membrane tethered lipid second 
messenger phosphatidylinositol (3,4,5) triphosphate (PIP3) by Phosphatidylinositol 3’ 
–kinase (PI3K) (Engelman et al. 2006). PIP3 attracts proteins with a pleckstrin homology 
(PH) domain to the plasma membrane and brings these proteins into proximity with 
each other to interact (DiNitto et al. 2003). A protein phosphatase PTEN counteracts 
the function of PI3K by dephosphorylating PIP3 to PIP2 thereby releasing proteins 
from the membrane and disrupting the pathway (Maehama et al. 1998). One of the PH 
domain-containing proteins is Akt which, once it is tethered to the membrane, becomes 
phosphorylated and activated by Phosphoinositide-dependent kinase 1 (PDK1) and 
Target of rapamycin complex 2 (TORC2) (Franke et al. 1997, Klippel et al. 1997, Alessi 
et al. 1997, Sarbassov et al. 2005). The activity of Akt is known to be directly inhibited 
by several phosphatases. These include Protein phosphatase 2A (PP2A) (Ugi et al. 2004, 
Van Kanegan et al. 2005, Padmanabhan et al. 2009) and PH domain leucine-rich repeat 
protein phosphatase (Gao et al. 2005). Akt is a key player in promoting cell survival, 
growth and division having more than 100 known substrates (Manning & Cantley 
2007). The best known substrates directly involved in growth control include Glucose 
and serum regulated kinase 3 α and β (GSK3) (Cross et al. 1995), Tuberous sclerosis 
complex 2 (TSC2) (Inoki et al. 2002, Manning et al. 2002, Potter et al. 2002) and FoxO 
transcription factors (see p.13). The inhibition of the TSC1/2 complex by Akt makes 
a connection to another well defi ned nutrient regulated pathway, the TOR signaling 
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6pathway. The insulin-TOR signaling pathways form a network of interactions intricately 
balanced by nutrient availability, regulating processes such as energy metabolism and 
translation (Wullschleger et al. 2006). The coordinated activity of this network is the 
main growth regulator of a metazoan organism. In fi gure 1 the best known interactions 
within the Insulin and TOR signaling network are summarized.
The main physiological consequences of Insulin signaling activation are (1) cellular 
glucose, amino acid and fatty acid uptake, (2) production of energy reserves in the 
form of glycogen and fat and (3) releasing the cell from a cell cycle and translational 
arrest allowing cellular growth and division. In the latter, a main role is played by the 
regulation of the Forkhead box transcription factors (Figure 1 and see below).
Cyclic adenosine monophosphate signaling pathway
Cyclic AMP (cAMP) signaling is a well characterized nutrient and hormone regulated 
signaling pathway. Its role for transmitting the action of hormones, for example 
Glucagon, Epinephrine, Vasopressin and Corticotrophin, has been known for decades 
(Major & Kilpatrick 1972). Cyclic AMP is a ubiquitous intracellular second messenger 
Figure 1. The Insulin/TOR signaling network.
The balanced activity of this network regulates growth to meet the prevailing nutritional condi-
tion. An important consequence of the activation of the Insulin signaling is the sequestering of the 
FoxO transcription factors into the cytosol. The connection from TOR/Raptor complex to FoxO 
can be direct or through IRS (see discussion p.32). For the sake of simplicity only the best known 
interactions are illustrated.
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7in all animal cells. It is synthesized from ATP by an enzyme Adenylate cyclase (AC) and 
it is degraded by a Phosphodiesterase (PDE) which hydrolyzes it to AMP. The binding of 
a hormone to its cognate receptor results in production of active GTP-bound G-protein 
α-subunit which in turn binds to and activates the AC. In addition, the activity of AC is 
modulated through phosphorylation by PKC and binding to Ca2+/Calmodulin (Hurley 
1999). The formation of cAMP can then stimulate multiple different processes which 
include gluconeogenesis, secretory processes, apoptosis and growth control (Houslay & 
Milligan 1997). Hence, the pathway is a general signaling mechanism used in all cells 
and the outcome of its stimulation depends on various factors associated with cell type 
and signal strength.
The classical outcome of increasing cellular cAMP levels is the activation of the 
cAMP dependent protein kinase A (PKA) which is a tetrameric holoenzyme consisting 
of catalytic and regulatory sub-units. The binding of cAMP releases PKA from its 
regulatory sub-units yielding an active enzyme (Skålhegg & Tasken 2000). The signal 
generated by cAMP is then transmitted to the nucleus by cAMP-response-element-
binding protein (CREB) phosphorylated and activated by PKA (Gonzales & Montminy 
1989, Sands & Palmer 2008). CREB acts as a transcription factor by binding to the core 
cAMP response element (CRE) sequence TGACGTCA (Carlezon et al. 2005) (Figure 
2). In the liver, Glucagon stimulates the activation of CREB which acts in concert with 
Figure 2. cAMP signaling pathway.
The activation of the G-protein coupled receptor (GPCR) by Glucagon leads to the activation of 
Adenylate cyclase (AC) and production of cAMP. cAMP activates PKA and CREB transcription 
factor leading to the activation of transcriptional program of gluconeogenesis.
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8coactivators Peroxisome-proliferation-activated receptor-γ coactivator-1 (PGC-1α), 
CREB binding protein (CBP), Transducer of regulated CREB activity 2 (TORC2) and 
FoxO1 to induce the program of gluconeogenesis under fasting conditions (Chrivia et al. 
1993, Herzig et al. 2001, Puigserver et al. 2003, Koo et al. 2005). This program of gene 
expression is inhibited by Insulin demonstrating the intimate link between the cAMP and 
Insulin signaling pathways (Zhou et al. 2004). In summary, in regard to metabolism and 
growth, the cAMP signaling pathway acts as a starvation signal activated by Glucagon, 
resulting in the release of energy from the liver.
Protein kinase C signaling
Protein kinase C (PKC) is a close relative of PKB/Akt and PKA which form the 
family of ABC kinases (Newton 2003). PKCs itself form a family of kinases divided 
into the conventional (cPKC), atypical (aPKC) and novel isoforms (nPKC), classifi ed 
on the basis of their domain structure and co-factor regulation (Newton 2001). PKCs 
are important mediators of the Insulin signaling having both inductive and repressive 
functions depending on the cell type and activated isoform. Overall, six out of the 
ten known mammalian PKC isoforms are implicated in Insulin signaling (Sampson 
& Cooper 2006). However, their role as negative regulators of Insulin signaling and, 
consequently, enhancers of Insulin resistance is more profoundly understood. Especially, 
their involvement in the free fatty acid (FFA) induced Insulin resistance is well 
established (Schmitz-Peiffer et al. 1997, Letiges et al. 2002, Yu et al. 2002, Puljak et 
al. 2005). Some PKC isoforms are also connected to the MAPK pathways in various 
cell types having direct effects on proliferation and cancer (Ueda et al. 1996, Skaletz-
Rorowski et al. 2005, Cozzi et al. 2006). As mentioned above, PKC is also known to 
be involved in the cAMP signaling by regulating the activity of the Adenylate cyclases. 
These examples of interactions demonstrate how intimately the pathways regulating 
metabolism and growth are linked.
PKCs are activated through various growth factor receptors and by second 
messengers. These include (1) diacylglycerol (DAG), a glycerolipid derivative, (2) Ca2+/
calmodulin and (3) phosphatidylserine (PS), a membrane phospholipid. Specifi cally, 
there are two requirements to fully activate PKC; phosphorylation and the presence 
of a subfamily-specifi c second messengers acting as a cofactor. PKC goes through 
three sequential phosphorylations to take its mature form. First, it is phosphorylated 
at a residue in its activation loop catalyzed by PDK1 (similar to PKB and PKA) and 
second, it goes through two autophosphorylation events which enable the enzyme 
to adopt a catalytically competent confi rmation and allows it to be released into the 
cytosol. The three phosphorylation events result in a number of key conformational 
rearrangements that lock PKC into a more thermally stable, protease and phosphatase 
resistant conformation (Cazaubon et al. 1994, Orr & Newton 1994, Keränen et al. 1995, 
Le Good et al. 1998).
Upon activation and release into the cytosol from the cell membrane, PKC can 
phosphorylate its substrates. PKC isoforms are known to have multiple targets for 
phosphorylation such as other kinases, signaling adapter proteins and transcripton 
factors (Hurov et al. 2004, del Rincon et al. 2004, Wang et al. 2005, Holden et al. 2008, 
Yamasaki et al. 2009). An important PKC substrate is the Insulin receptor substrate 1 
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(IRS-1) which is an adapter protein linking Insulin receptor and PI3K (Ogawa et al. 
1998). The levels of IRS-1 are regulated by a proteasome dependent mechanism and 
deregulation of this process is known to be associated with Insulin resistance in humans 
and rodent diabetes models (Saad et al. 1992, Tamemoto et al. 1994, Rondinone et 
al. 1997, Zhande et al. 2002). It has been shown that PKC inhibits insulin signaling 
through IRS-1 phosphorylation (Leitges et al. 2002). In addition, del Rincon et al. 
(2004) demonstrated that IRS-1 is a direct substrate of a nPKC isoform, PKCδ, having 
implications in IRS-1 proteosomal degradation. It has been suggested that PKC serves 
as a physiological feedback mechanism to inhibit elevated Insulin signaling (Leitges et 
al. 2002).
From the above considerations it becomes evident how complicated network 
of signaling events are involved in the regulation of the metabolism and growth of 
a metazoan organism. It is noteworthy that in the course of mammalian evolution 
most of the signaling molecules have gone through several duplication events. 
These homologues have nowadays redundant and independent functions making the 
investigation of a signaling pathway extremely challenging. Importantly, in lower 
eukaryotes gene duplication events have been rather rare, leaving the signaling pathways 
easier to interpret. For example, comparison of the Insulin signaling pathway between 
mammals and Drosophila reveals a lack of redundancy in many pathway components 
in the latter (Figure 3). Hence, the employment of model organisms such as Drosophila 
melanogaster can have a profound impact in the understanding of cellular signaling.
Forkhead box class “O” transcription factors
Forkhead box class “O” (FoxO) transcription factors are a family of conserved proteins 
belonging to the large superfamily of forkhead box, or winged-helix, transcription 
factors. The superfamily consists of 19 sub-classes termed from FoxA to FoxS having at 
Figure 3. The Insulin signaling pathway in mammals and Drosophila
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present more then 100 known family members throughout the animal kingdom. These 
proteins are classifi ed solely based on the existence of the approximately 100-amino acid 
long forkhead DNA binding domain. The position of the domain can vary greatly within 
the family and not all of the members are considered to be transcriptional activators. For 
example, FoxP is thought to be a transcriptional repressor since it lacks a transactivation 
domain characteristic to transcriptional activators (Wang et al. 2003). FoxO proteins are 
unique in having a fi ve amino acid insertion (GDSNS) in their DNA binding domain 
(Weigelt et al. 2001). The function of this short stretch of amino acids is not known. The 
members of the forkhead box family are commonly known to associate with metazoan 
development but lately a variety of different biological functions have been associated 
with these proteins.
Short historic perspective
The fi rst forkhead family member was characterized from a genetic screen looking for 
defects in embryogenesis in the fruit fl y Drosophila melanogaster (Jurgens & Weigel 
1988). Mutations in this gene caused a homeotic transformation of the embryo’s 
posterior segments into head-like structures. The gene responsible for this “forked head” 
embryo was named after its phenotype and cloning of the gene soon followed (Weigel 
et al. 1989). The gene was found to contain a putative DNA binding domain unknown 
at that time. Subsequently, fork head has been classifi ed as a member of the forkhead 
box class “A” family. The sequence of the fork head DNA binding domain has been 
then used for characterization of other members of the forkhead box superfamily in 
diverse species. The crystal structure of the forkhead domain in complex with DNA was 
published already in 1993 by Clark et al.
To date, four functional foxo genes are known in mammals. The first FoxO-
encoding gene was reported in humans in 1993 (Galili et al. 1993). It was found in 
the breakpoint of a chromosomal fusion in chromosome t(2;13)(q35;q14) associated 
with alveolar rhabdomyosarcoma, a type of cancer formed in the skeletal muscle at 
early ages. The gene was named as fkhr (forkhead in rhabdomyosarcoma) but was later 
renamed as foxo1 by a winged helix/forkhead nomenclature committee (Kaestner et al. 
2000). Since the identifi cation of foxo1, three other FoxO members have been found 
in the human genome; foxo3 (Anderson et al. 1997, Hillion et al. 1997), foxo4 (Parry 
et al. 1994, Borkhardt, et al. 1997) and foxo6 (Jacobs et al. 2003).The genes foxo3 and 
foxo4 were also found in chromosomal translocation sites, both associated with acute 
leukaemia. FoxO6 is sometimes not included in the family since it has distinct regulatory 
properties from other FoxO proteins. Initially, foxo3 was identifi ed independently by two 
groups and was for a short time thought to be two different genes. Hence, foxo2 was 
later omitted from the nomenclature. For foxo1, and foxo3, additional homologous open 
reading frames have been found that contain a stop codon preventing the synthesis of 
full length proteins (Anderson et al. 1997). These are thought to represent pseudogenes 
and are sometimes referred as foxo1b and foxo3b.
Parallel to the fi ndings in humans, FoxO members were cloned in other organisms as 
well. Biggs et al. (2001) cloned three mouse genes highly homologous to human foxo1, 
foxo3 and foxo4. In the same study, single orthologues from the chick (Gallus gallus) 
and zebrafi sh (Danio rerio) were found. The mouse foxo6 was later cloned parallel to 
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the human orthologue by Jacobs et al. in 2003. The sole nematode worm Caenorhabditis 
elegans FoxO member, daf-16, was identifi ed by Ogg et al. as early as 1997. Since then, 
studies with C. elegans have provided much of the knowledge of the biological functions 
of FoxO proteins. The single Drosophila melanogaster FoxO ortholog (dFoxO) was 
reported independently by three different groups in 2003 (Junger et al. 2003, Kramer et 
al. 2003, Puig et al. 2003). Subsequently, Drosophila has become the animal model most 
widely used to discern different properties of FoxO biology.
Molecular function, structure and conservation of FoxO proteins
FoxO proteins are sequence-specifi c DNA binding proteins with transcription factor 
activity. The core DNA binding sequence of FoxO proteins, TTGTTTAC, has been 
determined (Furuyama et al. 2000). FoxO proteins possess the characteristic domain 
structure of transcription factors (Figure 4). Roughly, the protein can be divided into 
two parts; the DNA binding domain and the transactivation domain. The DNA binding 
forkhead domain, also called as the winged-helix domain, contains a helix-turn-helix 
core of three α-helices fl anked by two large loops or wings. In this conformation, helix 3 
is responsible for most of the direct contact with DNA (Clark et al. 1993). The structure 
of the human FoxO4 DNA binding domain has also been determined. It was found 
that the fi ve amino acid insertion characteristic of FoxO proteins, adds a small loop 
between helix 1 and 2 but has little effect on the overall structure (Weigelt et al. 2001). 
Therefore the target gene specifi city could not be attributed to the forkhead domain and 
remains elusive. Interestingly, similar topology is used by several other DNA binding 
proteins with a completely unrelated amino acid sequence representing a nice example 
of convergent evolution at the molecular level (Carlsson & Mahlapuu 2002). Within the 
forkhead domain there is a short stretch of sequence rich in basic amino acids, denoted 
as nuclear localization signal (NLS) (Qian & Costa 1995). This motif is responsible for 
its nuclear localization, and in FoxO proteins it is one of the main sites targeted by FoxO 
regulators (Biggs et al. 1999, Brunet et al. 1999). Additional to the NLS, two leucine 
rich nuclear export signals (NES) are present in the carboxy terminal sequence of FoxO 
proteins (Biggs et al. 1999, Brunet et al. 2002).
The FoxO family share very little similarity at the protein sequence level, with the 
exception of the DNA binding forkhead domain where human FoxO4 and Drosophila 
dFoxO share 45% overall identity and 85% identity in the region of the three α-helices 
(Puig et al. 2003). Apart from the forkhead domain, FoxO and other forkhead box 
Figure 4. Schematic representation of the characteristic domain structure of a FoxO 
protein.
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family member proteins differ signifi cantly in their sequence. Little is known how the 
putative transactivation domain contributes to the interaction with the transcriptional 
apparatus or to target gene specifi city. Additionally, the exact position of this domain 
within the protein varies signifi cantly in literature. Only a few studies have addressed the 
position of the so called activation or repression domains in different forkhead proteins 
responsible for protein-protein interactions. For example, Hellqvist et al. (1998) showed 
the existence of two activation domains in human Forkhead-related activator 2 protein 
that are responsible for contacts with the general transcription factors TATA-binding 
protein and TFIIB. At present, little is known about these domains in FoxO proteins.
Regulation of FoxO activity
The metazoan gene expression machinery is highlighted by its multiple level of 
regulation. For example, expression of a given gene is dependent on factors such as 
chromatin structure and the availability and activity of regulatory trans-activating 
proteins. These inducible transcription factors are present, or their activity is modulated, 
in temporal and spatial patterns and are responsible for most of the gene expression 
specifi city in a given tissue or developmental process. Studies of FoxO activity regulation 
have been concentrated on the post-translational level. At present little is known how the 
expressions of foxo genes are regulated. Interestingly, a recent study by Essaghir et al. 
(2009) demonstrated the presence of FoxO recognition elements (FRE) in the FoxO1 
gene. It was further shown that FoxO1 and FoxO3 regulate their own expression by 
binding to these sequences in human fi broblasts. The prevalence of such a regulation in 
other cell types and organisms is yet to be determined.
During Drosophila development dfoxo is expressed ubiquitously throughout the 
embryo (J. Mattila, unpublished observation). A similar observation has been made 
in mice where different FoxO isoforms occupy different tissues during development 
resulting in nearly uniform expression (Furuyama et al. 2000). Furthermore, critical 
FoxO functions such as stress and metabolism response, as well as cell cycle regulation 
(see below), require rapid changes in activity. This implies that most of the regulation 
during development as well as in maintaining cellular homeostasis is achieved at the 
post-translational level. Indeed, FoxO is known to be regulated through phosphorylation, 
acetylation, methylation and ubiquitylation.
In principal, FoxO activity can be modulated in three different ways: (1) by 
sub-cellular localization between nucleus and cytoplasm, (2) by regulated protein 
stabilization/destabilization and (3) by post-translational modifi cations altering its DNA 
and/or transcriptional cofactor binding capacity. All of these mechanisms have been 
shown to play a role in regulating FoxO activity. All the known FoxO proteins, except 
FoxO6, are regulated through phosphorylation by Protein kinase B (PKB/Akt) or a 
redundant Serum and glucocorticoid inducible kinase (SGK), which modulates transport 
between the nucleus and cytoplasm (see below). Protein localization and degradation are 
coupled since in the cytoplasm FoxO is ubiquitynated and targeted for degradation to the 
proteasome (Matsuzaki et al. 2003, Plas & Thompson 2003). Furthermore, FoxO activity 
can also be modulated while in the nucleus. Luong et al. (2006) have shown that nuclear 
dFoxO activity is at least partially dependent on the Target of rapamycin (TOR) kinase. 
Additionally, Tsai et al. (2003) demonstrated that nuclear exclusion is not necessary for 
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Akt mediated inhibition of FoxO1. In addition, FoxO1 is shown to be methylated by 
protein arginine methyltransferase PRMT1 which protects it from the negative regulation 
by Akt (Yamagata et al. 2008). Finally, acetylation by histone acetyltransferases such as 
CREB-binding protein and p300 can weaken the DNA binding of FoxO (van der Horst 
& Burgering 2007).
Multiple signaling pathways are known to affect FoxO activity (Huang & Tindall 
2007). At present, emphasis is put on the regulatory phosphorylation events by various 
kinases. Below are reviewed the best known interactions between FoxO and its 
regulatory kinases.
Regulation of FoxO by Akt
The fi rst indication that Insulin signaling and FoxO interact, came from observations 
in C. elegans where a long lived daf-2 mutant (abnormal dauer formation-2, worm 
orthologue of InR) was suppressed by a mutation in a daf-16 gene (Gottlieb & Ruvkun 
1994, Larsen et al. 1995). The daf-16 gene was soon after characterized to represent 
the worm FoxO transcription factor ortholog (Ogg et al. 1997). Only two years later, 
it was directly demonstrated by a combined effort of six different groups that Insulin 
signaling inhibited mammalian FoxO activity by Akt mediated phosphorylation in three 
serine/threonine residues (Thr32, Ser253 and Ser315 in FoxO3 sequence) (Biggs et al. 
1999, Brunet et al. 1999, Kops et al. 1999, Nakae et al. 1999, Rena et al. 1999, Tang 
et al. 1999). Interestingly, FoxO6 lacks these phosphorylation sites and it is therefore 
regulated independently of Akt, remaining predominantly nuclear (Jacobs et al. 2003). 
The phosphorylation events were shown to result in the association of FoxO with the 14-
3-3 chaperone proteins leading to subsequent cytoplasmic retention and transcriptional 
inactivation (Brunet et al. 1999). The mechanism by which 14-3-3 facilitates the nuclear 
exclusion of FoxO is not fully understood. However, it has been shown that both 
phosphorylation of FoxO by Akt and interaction with 14-3-3 are necessary requirements 
for FoxO nuclear exclusion (Brunet et al. 2002). One possible explanation is that these 
events lead to a conformational change and exposure of the NES signals to the nuclear 
export machinery (Brunet et al. 2002). An alternative view is presented by Brownawell 
et al. (2001) who suggest that Akt mediated phosphorylation attenuates nuclear import 
rather then augments export. Whatever the exact mechanism, it has been shown to be 
a conserved feature in FoxO regulation. The consensus Akt phosphorylation sites are 
also present in dFoxO and conversion of these residues (T44, S190 and S259 in dFoxO 
sequence) to alanines results in constitutively nuclear FoxO protein (Puig et al. 2003). 
These mutant forms are widely exploited in FoxO research nowadays and sometimes 
inaccurately referred to as constitutively active.
Regulatory network around FoxO
Besides Akt/SGK, FoxO is known to be phosphorylated by at least eight different kinases 
(Table 1). To date, only one FoxO specifi c phosphatase, PP2A, has been identifi ed (Yan 
et al. 2008). Interestingly, PP2A has also been found to directly regulate Akt activity 
(Padmanabhan et al.  2009). Many of the phosphorylation events are associated with 
facilitated nuclear exclusion and transcriptional inactivation. These include Casein 
kinase 1 (CK1) (Rena et al. 2002), dual-specifi city tyrosine-phosphorylated and regulated 
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kinase 1A (DYRK1) (Woods et al. 2001), Ikappaβ kinase (IKKβ) (Hu et al. 2004) and 
Cyclin dependent kinase 2 (CDK2) (Huang et al. 2006). In addition, members of the 
mitogen activated protein kinase Extracellular signal-regulated kinase and p38 have been 
shown to phosphorylate and inactivate FoxO by a localization-independent mechanism 
(Asada et al. 2007). Phosphorylation can also lead to enhanced nuclear localization and 
transcriptional activation as it has been shown with Jun N-terminal kinase (JNK) (Essers 
et al. 2004, Oh et al. 2005, Wang et al. 2005) and Mammalian sterile 20-like kinase-1 
(MST-1) (Lehtinen et al. 2006). Furthermore, the AMP-activated protein kinase (AMPK) 
phosphorylates and activates FoxO without modulating its sub-cellular localization 
(Greer et al. 2007).
Table 1. Kinases known to phosphorylate FoxO.
Kinase Reference
Akt/SGK Biggs et al. 1999, Brunet et al. 1999, Kops et al. 1999, Nakae et al. 1999, Rena et al. 1999, Tang et al. 1999
cGKI Bois et al. 2005
IKKβ Hu et al. 2004
DYRK Woods et al. 2001
CDK2/1 Huang et al. 2006, Yuan et al. 2008
JNK Essers et al. 2004
MST-1 Lehtinen et al. 2006, Yuan et al. 2009
CK1 Rena et al. 2002
AMPK Greer et al. 2007
 As with any other molecular interaction data, critical evaluation of the reported 
information is necessary. In other words, probability that an interaction represents 
biological signifi cance is enhanced when (1) a regulatory event and/or site in a protein 
is conserved among species and (2) interruption of the interaction results in a phenotype 
in vivo. Based on this classifi cation, convincing evidence as FoxO regulators has been 
presented for Akt, IKKβ, CDK2, JNK, AMPK and MST-1. These interactions and their 
consequence in vivo are discussed below.
IKKβ
The IKKβ kinase is an important positive regulator of cell survival and proliferation by 
activating members of the NF-kB transcription factors. The IKKβ - NF-kB interaction 
has known implications in infl ammation and cancer (Schmid & Birbach 2008). Hu et 
al. (2004) demonstrated beautifully how IKKβ contributes to the pathogenesis of cancer 
by regulating FoxO3 activity. Their study is an example of excellent characterization 
of a molecular interaction. The initial fi nding was that in a signifi cant number of breast 
cancer specimens, FoxO3 was localized to cytoplasm even in the absence of active Akt. 
The authors found that cytoplasmic FoxO3 correlated with Akt and IKKβ staining in 
most of the breast cancer samples as well as in lung, liver and stomach carcinomas. 
It was then further shown by biochemical analysis that IKKβ modulates the FoxO3 
transcriptional activity by phosphorylation and nuclear exclusion. The seminal fi nding 
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from the study was that cytoplasmic FoxO3 correlates with Akt and/or IKKβ activity 
and that this condition yields poor prognosis among breast cancer patients.
The fi ndings of Hu et al. (2004) emphasize the importance of developing anti-
cancer treatment with both Akt and IKKβ inhibitory function, since inhibition of Akt 
alone is not suffi cient to restore FoxO3 activity. Accordingly, IKKβ inhibitory drugs 
are currently a target of intense development and some molecules are already in clinical 
trials (Schmid & Birbach 2008). However, the relevance of this interaction in regard 
to normal cell growth and/or development is still to be elucidated since at present no 
studies address it in untransformed cells.
CDK2
CDK2 is a critical player of the cell cycle machinery by controlling the entrance and 
progress of the S-phase together with E and A-type of cyclins, respectively. Given its 
role in driving cells to the replication cycle and maintenance of DNA synthesis in S-
phase, it is a key target of inactivation upon induction of G1 or intra S-phase checkpoint 
by double strand break (DSB) (Huang & Tindall 2007). DSB can arise from by-products 
of innate metabolism (reactive oxygen species, ROS) or from environmental genotoxic 
agents such as UV-light. The DSB checkpoint ensures slowing down DNA replication 
giving time for the repair machinery to correct the DNA damage or to drive the cell 
to apoptosis (Bartek et al. 2004). Huang et al. (2006) demonstrated that an important 
regulatory mechanism upon DSB is the relief of FoxO1 transcription factor, but not 
FoxO3 or FoxO4, from CDK2 mediated inhibition. They showed that CDK2 physically 
interact and phosphorylate a Ser249 residue on FoxO1 resulting into its cytoplasmic 
localization. Blocking of the phosphorylation by a Ser249 conversion to alanine leads 
to elevated apoptosis. The critical observation was, however, that the CDK2 mediated 
phosphorylation of FoxO1 could be reversed under genotoxic stress. This finding 
demonstrated that the interaction is biologically meaningful and suggest that FoxO1 
has an important role in protecting the organism from DNA damage and cancer. 
Interestingly, Liu et al. (2008) have demonstrated that CDK1 is also inactivating FoxO1 
by directly phosphorylating the Ser249 residue in prostate cancer cells. In addition, the 
same mechanism was found to operate in postmitotic neurons and proliferating cells, 
but with completely opposite outcome (Yuan et al. 2008). Phosphorylation of FoxO1 at 
Ser249 by CDK1 resulted in its nuclear accumulation and induction of FoxO1 dependent 
gene expression. These opposing results demonstrate how cellular signaling can be 
disrupted in cancer cells. In addition, it raises the question how the phosphorylation 
of the same residue by separate kinases can result in completely different outcome in 
regard to FoxO activation. As a conclusion, the results presented above imply that a 
more general interaction between Cyclin dependent kinases and FoxO exists.
JNK
Jun N-terminal kinase (JNK) is a member of the well defi ned, conserved family of 
mitogen-activated protein kinases (MAPK). The JNK pathway is one of the most studied 
signaling cascades and has been implicated in numerous processes (Lin 2003, Nishina 
et al. 2004). It is considered as a general intracellular transduction mechanism whose 
outcome is dependent on the type of activating stimulus and cellular constituents. For 
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example, it is well known for its apoptosis stimulating function upon cellular stress 
caused by ROS and reactive nitrogen species (RNS) (Shen & Liu 2006). On the other 
hand, it has been shown to be involved in the regulation of the complex process of tissue 
regeneration (Mattila et al. 2005). The fi rst evidence that some JNK regulated processes 
are mediated through FoxO came from the studies of Essers et al. (2004). They showed 
in mammalian cell culture that JNK induces nuclear localization and transcriptional 
activation of FoxO4 upon increased ROS levels. They also demonstrated that the 
interaction between FoxO4 and JNK is direct; JNK phosphorylates the threonine 447 and 
451 of FoxO4. Interestingly, Essers et al. (2004) could not reveal the mechanism of the 
sub-cellular translocation event since FoxO4 binding to the 14-3-3 chaperone was not 
affected by the phosphorylation event. Hence, it would be very interesting to elucidate 
how these modifi cations change FoxO localization, especially since those residues are 
located at the C-terminal transactivation domain. Sunayama et al. (2005) came up with a 
suggestion to the problem by showing that JNK actually phosphorylates 14-3-3 proteins 
too, and this modifi cation dissociates it from its substrates.
In 2005 two groups working with the model organisms C. elegans (Oh et al. 2005) 
and D. melanogaster (Wang et al. 2005) demonstrated the physiological signifi cance 
of the interaction between JNK and FoxO in vivo. Their work elegantly showed that 
the JNK-FoxO interface is critical in mediating organism homeostasis and defects 
in this regulation lead to premature death. Wang et al. (2005) took the mechanistic 
explanation even further by showing that JNK extends its function by a cell non-
autonomous manner. This is achieved by activating dFoxO in the Insulin producing cells 
(IPC) thereby inhibiting Drosophila Insulin like peptide (DILP) release. Remarkably, 
fl ies overexpressing activated Hemipterous, a JNK activating kinase in the IPC cells, 
are smaller then the controls. This effect was dFoxO dependent since in the dfoxo null 
background the phenotype was reversed. These results suggest an interesting possibility 
that both Insulin and JNK signaling converge on FoxO having the opposite effects. An 
important downstream effect of this regulation would be the production of the DILPs, 
which guide the growth and metabolism of peripheral tissue. Accordingly, Insulin 
and JNK signaling are balancing the organism growth by perceiving and transmitting 
information about energy homeostasis and oxidative stress state, respectively.
AMPK
The AMP activated protein kinase (AMPK) is an energy sensing heterotrimeric (α, β 
and γ subunits) protein complex integrating the cellular AMP/ATP ratio into a response 
aiming to maintain energy homeostasis. AMPK is activated by high levels of 5’AMP 
which is antagonized by the increase in ATP concentration (Hardie & Sakamoto 2006). 
AMPK has both systemic and cell autonomous functions. In hypothalamus, AMPK 
regulates the production of neuropeptides involved in food intake and growth (Minokoshi 
et al. 2004). One important downstream target of AMPK is Tuberous sclerosis complex 
2 (TSC2) (Inoki et al. 2003). By phosphorylating TSC2, AMPK inhibits the TOR 
pathway and has therefore an important impact on cellular growth. Given that FoxO is 
involved in cellular energy homeostasis by activating the mechanisms releasing energy 
from cell reserves it was not surprising that Greer et al. (2007a) found an interaction 
between AMPK and FoxO. The authors demonstrated that at least two novel FoxO3 
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sites, Ser413 and Ser588, were phosphorylated by AMPK in mammalian cell culture. These 
sites are present in the transactivation domain and their phosphorylation confers the 
ability of FoxO to activate transcription but does not affect its sub-cellular localization 
or affi nity to DNA. Interestingly, by using a combination of mutated FoxO3 protein and 
microarray profi ling, Greer et al. (2007a) found a subset of FoxO3 regulated genes that 
were specifi cally up-regulated by AMPK through FoxO3. This experimental approach 
was able to unambiguously demonstrate that FoxO gene specifi city is achieved upon 
differential phosphorylation by upstream activating kinases. Since the affi nity to DNA 
was not affected by AMPK mediated phosphorylation, it is likely that the gene specifi city 
is achieved by interaction with co-activators within the transcriptional apparatus. An 
intriguing possibility would be to use the AMPK insensitive FoxO3 mutant to identify 
these factors by comparing the binding partners of WT and mutant FoxO3. Importantly, 
the same group was able to show the conservation and biological signifi cance of the 
AMPK-FoxO pathway in C. elegans (Greer et al. 2007b). By using genetic experiments 
the authors showed that life span increase induced by dietary restriction (DR) is mediated 
by the AMPK-FoxO interaction.
Taken together, the results of Greer et al (2007a, 2007b) suggest that upon attenuated 
cellular energy levels, AMPK becomes activated and further activates FoxO to mediate 
a transcriptional response. FoxO activated transcription then, in turn, enhances cellular 
mechanisms to protect cells from energy deprivation and stress. A Defect in this 
regulatory mechanism lead to premature death upon DR. Related to this topic is the 
possible interaction between AMPK and Insulin signaling. Activation of AMPK and 
increased Insulin sensitivity are known to correlate in muscle cells (Fisher et al. 2002). 
Both, elevated AMPK activity and Insulin sensitivity can be achieved by, for example, 
increased exercise. In addition, anti-diabetic drugs rosiglitazone and metformin activate 
AMPK in muscle cells (Fryer et al. 2002). Insulin receptor substrate 1 (IRS-1) is known 
to be phosphorylated by AMPK in cell culture and this leads to elevated signaling activity 
(Jacobsen et al. 2001). However, whether this activation is suffi cient for the enhanced 
Insulin sensitivity is not known. It is tempting to speculate that FoxO might play a role 
in this setting through transcriptional feedback regulation of InR (Puig & Tjian 2005). 
In fact, FoxO gain of function has been shown to enhance Insulin sensitivity in the liver 
(Matsumoto et al. 2006). Further studies are necessary to elucidate a mechanism for 
these observations.
MST-1
MST-1 belongs to the so-called Hippo pathway, named after its fi rst identifi ed member 
in Drosophila, the Hippo-kinase. The pathway is known to restrict organ growth in 
Drosophila and mammals and dysregulation of the pathway leads to tumorigenesis 
(Dong et al. 2007). An elegant study of Lehtinen et al. (2006), representing an excellent 
characterization of protein-protein interaction, demonstrated the conserved interplay 
and biological function of the MST-1-FoxO proteins. In this paper the authors observed 
neuronal death induced by MST-1 mediated oxidative stress and found a transducer, 
FoxO3, responsible for the phenomenon. Not only they showed that MST-1 directly 
phosphorylate and activate FoxO3, but the authors were also able to illustrate the 
mechanism behind it; MST-1-dependent phosphorylation of four serines in the forkhead 
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domain dissociates FoxO3 from the 14-3-3 proteins and reallocates it to the nucleus. 
Finally, Lehtinen et al. (2006) took their fi ndings into the model organism C. elegans 
to reveal the biological signifi cance of the interaction. Their experiments demonstrated 
that the worm orthologue of MST-1 modulates life span in both loss- and gain-of-
function conditions. In the case of long lived worms upon MST-1 overexpression, loss-
of-function in foxo orthologue was able to suppress this phenotype. The same group 
also demonstrated similar interaction between MST-1 and FoxO1 in the in primary 
rat cerebellar granule neurons where the MST-1 induced neuron death was FoxO1 
dependent (Yuan et al. 2009).
Biological functions of FoxO
Two common themes arise from the considerations described above on the regulation 
of FoxO activity. These are growth and protection from sub-optimal conditions such as 
energy deprivation and oxidative stress. Indeed, most of the reported FoxO functions are 
somehow related to these biologically essential and interconnected processes explaining 
the evolutionary conservation of FoxO between distant phyla. In the following section, 
the participation of FoxO in these processes and the consequences to organism well 
being are discussed. It has to be kept in mind that many, if not all, of the biological 
processes where FoxO is involved, are somehow linked and should be therefore 
considered as a whole. For example, the role of FoxO as a stress response agent upon 
DNA damage or nutrient shortage can not be separated from its function in cell cycle 
and energy metabolism and ultimately, in life span regulation.
Cell differentiation
Hribal et al. 2003 showed that myogenic differentiation, i.e. formation of multinuclear 
fusion cells, requires FoxO1 inhibition in mouse C2C12 myoblast cells. This observation 
was in agreement with previous fi ndings that IGF/PI3K/Akt signaling is required for the 
execution of myogenic program in these cells (Lawlor & Rotwein, 2000). Interestingly, 
FoxO1’s role in this process seems to be the repression of certain differentiation inducing 
genes, such as myogenin (Hribal et al. 2003). According to the authors, relief of this 
repression by Akt mediated FoxO1 phosphorylation then induces cell differentiation. 
Remarkably, a completely opposite mode of action has been reported by Bois & Grosveld 
(2003). The authors demonstrate that FoxO1 nuclear localization and activity correspond 
and is required for mouse myotube fusion and differentiation. In addition, this regulation 
was independent of PI3K/Akt signaling. The striking contrast between the studies of 
Hribal et al. (2003) and Bois & Grosveld (2003) is most likely refl ecting the differences 
in experimental systems which induced the differentiation. The myoblast fusion can be 
induced by either growing the cells into confl uence or by sudden serum withdrawal, the 
latter being the commonly used method. These two in vitro differentiating procedures 
have opposite effects to FoxO1 localization and activity. This was later demonstrated by 
Bois et al. (2005). It is interesting to note how very different experimental approaches 
can result in similar outcome, in this case cellular differentiation. It emphasizes the 
critical evaluation of widely employed methodology. Nonetheless, in an elaborate study 
by Bois et al. (2005) the role of FoxO1 upon confl uence induced differentiation was 
demonstrated. The authors showed that FoxO1 activity is required in the early steps 
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of myoblast fusion but it induces its own inhibition by induction of the expression of 
Cyclic GMP-dependent kinase I (cGKI). The cGKI was shown to phosphorylate and 
inhibit FoxO1. Both, early activity and later inhibition are required for proper myogenic 
differentiation. Similar to the myoblasts, modulation of FoxO1 activity has also been 
shown to be correlated with adipocyte differentiation (Nakae et al. 2003). In these 
experiments differentiation is induced in vitro by addition of Insulin into the culture 
medium. How accurately these differentiation methods refl ect the situation of myoblast/
adipocyte differentiation in vivo is yet to be clarifi ed.
Growth
Growth is fundamental in maintaining and reproducing all forms of life. Growth can be 
separated into two distinct entities: (1) cellular growth, i.e. an increase of cell mass or 
volume achieved by accumulation of biomolecules, such as proteins and lipids, and (2) 
tissue/organism growth through cell proliferation, i.e. coordinated division of individual 
cells within a tissue or organism. Cellular growth and cell division are coupled since 
a cell needs to reach a critical size before its separation into two daughters can take 
place. Cellular growth and cell division rate within an organism varies signifi cantly 
depending on several parameters such as developmental stage, cell type and prevailing 
nutritional conditions, and it is regulated through various signaling pathways (Jorgensen 
& Tyers 2004). Further, cell growth and division are regulated in a cell autonomous and 
non-autonomous manner, the latter being modulated, for example, by humoral signals 
elicited from nutrient sensing organs such as pancreatic beta and alpha cells. FoxO has 
a well characterized role in cell autonomous regulation of cell division as a player in the 
complex Insulin/TOR signaling network (Figure 1). Defects in this regulatory circuit 
are known to associate with a plethora of human carcinomas (Altomare & Testa 2005). 
In addition, recent advances in understanding Drosophila growth regulation through 
non-autonomous hormonal signals in the organism level have proposed a central role for 
FoxO in this process too.
Cell autonomous growth regulation
The fi nding that FoxO is situated in the location of chromosomal breakpoint associated 
with cancer by Galili et al (1993) gave the fi rst indication of its involvement in cell 
proliferation control. In spite of signifi cant progress in the fi eld since then, it was not 
until recently that Paik et al. (2007) directly demonstrated that FoxO is indeed a tumour 
suppressor. The authors developed a conditional triple knockout mouse (foxo1, foxo3 
and foxo4) and found that this genotype developed aggressive lymphoblastic thymic 
lymphomas in addition to the age-progressive hamartomatous phenotype. However, 
since foxo1 null mice are embryonic lethal, the most comprehensive evidence of its 
growth regulatory function in vivo comes from the studies of Drosophila pioneered by 
Puig et al. (2003) and Junger et al. (2003). Their work demonstrated that overexpression 
of dFoxO inhibits proliferation, but not cell growth, in cell culture as well as in the fl y 
eye and wing. At least part of the tissue size reduction was achieved by necrotic cell 
death, caused by the dFoxO overexpression above physiological levels. Interestingly, 
the phenotype was found to be enhanced by reduced Insulin signaling consistent with its 
role as an inhibitor of FoxO activity (Junger et al. 2003). A concurrent study by Kramer 
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et al. (2003) reported also attenuated proliferation in vivo, but in contrast to previous 
observations, it was accompanied by reduced cell size. It must be noted that the cloned 
dFoxO protein used by Kramer et al. (2003) was truncated containing ten exons instead 
of eleven, and therefore possibly retained only partial activity. This is apparent from their 
overexpression studies where mild ubiquitous overexpression of the truncated dFoxO 
protein yielded viable, small fl ies whereas overexpression of the full length protein is 
lethal (Puig et al. 2003). Although diffi cult to explain, the results of Kramer et al. (2003) 
might refl ect altered FoxO activity and/or gene specifi city and should be interpreted with 
caution. 
The observation that cell size is not affected in vivo was at fi rst surprising since 
Puig et al. (2003) and Junger et al. (2003) identifi ed the eIF4E-binding protein (4EBP) 
as a direct transcriptional dFoxO target. 4EBP binds to the eukaryotic Initiation factor 
4E (eIF4E) and inhibits its binding to mRNA cap structure and initiation of translation 
(Mamane et al. 2006). The role of 4EBP as a negative growth regulator and as a target 
of TOR signaling has been well characterized in cell culture (Wullschleger et al. 2006). 
However, the general view about 4EBP is now being challenged by in vivo studies in 
Drosophila. Teleman et al. (2005) demonstrated that 4EBP is dispensable during normal 
growth but instead has a surprising function in fat metabolism. In fact, a new role of 
4EBP as regulator of energy metabolism upon nutrient deprivation has emerged (see 
below). These results highlight the importance of in vivo models to complement and 
verify the cell culture studies.
The function of FoxO as a regulator of proliferation was compromised by the 
fi nding that homozygous null dfoxo alleles were viable and manifested no obvious size 
phenotype (Junger et al. 2003). Actually, these fl ies have a slightly reduced wing size 
which is the opposite of what would be expected. However, it was found that the null 
dfoxo allele suppressed the growth phenotype of reduced Insulin signaling, characterized 
by smaller and fewer cells. Interestingly, only the cell number phenotype was suppressed 
whereas cell size was unaffected, suggesting that FoxO indeed mediates only the 
proliferative function of Insulin signaling (Junger et al. 2003). Taken together, the 
results from gain- and loss-of-function experiments are in favour of a view, that FoxO 
is dispensable during normal tissue growth but is necessary to hinder the growth rate 
whenever Insulin signaling is low, i.e. upon lack of nutrition or in conditions of stress. 
Therefore, under physiological growing conditions Insulin signaling is suffi cient to keep 
FoxO phosphorylated and inactive. Several studies in mammalian cell culture support 
this hypothesis (Collado et al. 2000, Medema et al. 2000, Nakamura et al. 2000, Kops 
et al. 2002). An interesting, still unresolved question is how FoxO is released from its 
inhibitory state? Is Insulin signaling always shut off when FoxO recovers its activity or 
is there a mechanism to overcome this inhibition without affecting the Akt activity?
Cell non-autonomous growth regulation
Growth in metazoan organisms is coordinated by signals, i.e. growth factors and 
hormones, emanating from endocrine tissues such as the pancreas and hypothalamus. 
In Drosophila, a major growth organizer at organism level is the Insulin-Adipokinetic 
hormone (Akh) axis. Insulin and Akh are synthesized from neuroendocrine cells of the 
bilateral pars intercerebralis in the central nervous system (i.e. Insulin producing cells, 
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IPCs) and of a subset of corpora cardiaca (CC) in the ring gland, respectively (Rulifson 
et al. 2002). The hormones are carried through axon projections to the heart from where 
they are released to the haemolymph (Rulifson et al. 2002). The system operating in the 
fl y is considered functionally analogous to the Insulin-Glucagon hormone control of 
energy metabolism and growth operating in mammals. The idea is supported by several 
studies showing defects in growth as well as lipid and carbohydrate metabolism in IPC 
ablated fl ies (Rulifson et al. 2002, Ikeya et al. 2002, Broughton et al. 2005). The analogy 
was recently formally demonstrated by Buch et al. (2008) whose results for the fi rst time 
identifi ed a downstream target gene for the fl y Insulin in the peripheral tissues, encoding 
an alpha Glucosidase enzyme. The IPC cells produce three of the seven Drosophila 
Insulin like peptides (DILPs 2, 3 and 5), which are structurally similar to the human 
preproInsulin (Brogiolo et al. 2001). Interestingly, the expression of these peptides is 
modulated by dFoxO. Overexpression of dFoxO in the fl y head fat body by a conditional 
driver caused a threefold decrease of dilp2 expression, whereas expression of dilp3 and 
dilp5 were only slightly affected (Hwangbo et al. 2004). In addition, Wang et al. (2005) 
showed by loss-of-function studies that dFoxO is modulating dilp2 expression in the 
IPCs and that it has direct consequences to the fl y growth. These studies indicate that 
dFoxO is suppressing the Insulin production in the fl y thereby inhibiting growth in a 
systemic fashion. Whether this interaction is direct or not is still unresolved. FoxO is 
also known to have systemic growth regulatory function in mammals by modulating 
pancreatic β cell proliferation and indirectly, through Pancreatic and duodenal homeobox 
factor-1, Insulin production (Gross et al. 2008). In addition, another function has been 
addressed to FoxO as a regulator of mammalian food intake through neuropeptide Y in 
the hypothalamus (Kim et al. 2006). Similar neuropeptide dependent growth regulation 
exists in Drosophila although the role of FoxO in this setting has not yet been addressed 
(Lee et al. 2004).
Cell cycle
The growth inhibitory function of FoxO requires a mechanistic explanation at the level 
of cell cycle regulation. Insight to this problem came from the studies of Medema et al. 
(2000) and Seoane et al (2004) who found that FoxO regulates the expression of p27kip1 
and p21cip1 in several mammalian cell lines. The function of these proteins arrests the cell 
cycle in G1. The p27
kip1 and p21cip1 proteins are important CDK inhibitors that interact 
with various cyclin-CDK complexes. One of the cell division promoting functions of 
the Insulin signaling is the phosphorylation and inhibition of p27kip1 through Akt (Fujita 
et al. 2002). Hence, carcinomas with hyperactive Insulin signaling suffer from the loss 
of p27kip1 expression and from inhibition of its activity by elevated phosphorylation. 
Another important cell cycle regulator, Cyclin D1/2 was shown to be repressed by FoxO 
(Ramaswamy et al. 2002). This down-regulation also results in G1 arrest. The exact 
mechanism of repression is yet to be clarifi ed, however, since it is possibly an indirect 
interaction. In addition to G1 arrest, Tran et al. (2002) have presented evidence suggesting 
that FoxO also has a role in regulating the entrance into mitosis at the G2 DNA integrity 
checkpoint. Their data show that FoxO3 activity delays the G2 progression and induces 
DNA repair mechanism upon genotoxic stress. They also identifi ed a candidate FoxO 
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target gene growth arrest and DNA damage-inducible protein 45 (gadd45) as mediator 
of the response.
As outlined above, multiple pieces of evidence indicate a role for FoxO as a factor 
slowing down or blocking completely the progression of the cell cycle. It is therefore 
understandable that the tumour promoting function of elevated Insulin signaling is at 
least partly mediated by the lack of FoxO activity. Keeping this in mind, it is surprising 
that FoxO is necessary for the successful completion of the cell cycle in mammalian 
cells. This staggering discovery was made by Alvarez et al. (2001). The author’s initial 
fi nding was that shutting down the PI3K signaling pathway activity was required for 
a cell to exit mitosis. They discovered that the activity of the pathway was gradually 
hindered towards the end of G2 allowing FoxO1 to enter to the nucleus, which in turn, 
activated cyclin B and polo like kinase expression. The results of Alvarez et al. (2001) 
explain why a subset of cells in a growing population always possesses nuclear FoxO, a 
phenomenon often encountered in the literature.
In summary, FoxO appears to have seemingly opposite functions in the cell cycle 
regulation depending on the stage that it is activated. In G0 or G1 poor growing conditions 
arrest the cell from committing to the cell cycle. This explains the negative effect of 
elevated FoxO activity to tissue growth observed in in vivo experiments (Puig et al 2003, 
Junger et al. 2003). On the other hand, oscillation in FoxO activity is a requirement in 
successful completion of the cell cycle. However, this function only affects a relatively 
small number of cells already committed to cell cycle progression. In both stages the 
activity of Insulin signaling inversely correlates with FoxO activity. How this fl uctuation 
in Insulin signaling activity is achieved in the presence of growth factors is a fascinating 
question. A solution to this problem would defi nitely open new gates in modulating 
Insulin signaling activity in pathogenic conditions, such as cancer.
Energy metabolism
The maintenance of correct blood glucose level is pivotal to organism homeostasis. An 
adaptive regulatory mechanism has evolved in metazoan organisms to respond to the 
lack of consumed energy between meals or upon prolonged starvation. During fasting, 
glucose is released from energy supplies stored in the form of glycogen and fat. The 
process is regulated through the action of Insulin and Glucagon, key metabolic hormones 
produced by the pancreatic beta and alpha cells, respectively.
FoxO proteins have a well characterized role in lipid and glucose metabolism in 
various tissues such as skeletal muscle, liver and pancreas. The regulation of organism 
energy homeostasis by FoxO is achieved by either direct means, through modulation 
of the expression of several genes involved in gluconeogenesis and triglyceride 
hydroxylation, or by indirect means by modulating the skeletal muscle and adipocyte 
tissue mass, the major glucose disposing tissues in humans (Gross et al. 2008). In 
essence, upon hypoglycaemia and subsequent attenuation of circulating Insulin, hepatic 
FoxO1 is localized into the nucleus where it activates a pattern of gene expression 
devoted to gluconeogenesis and lipid catabolism (Zhang et al. 2006). These include the 
key gluconeogenic enzymes Glucose-6-phosphatase (G6Pase) and Phosphoenolpyruvate 
carboxykinase (PEPCK) (Schmoll et al. 2000, Nakae et al. 2001, Zhang et al. 2006). 
As a result, the liver provides energy to the peripheral tissues by releasing glucose into 
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the bloodstream. In parallel, FoxO induces the utilization of fatty acids in myocytes as 
an energy source which is a characteristic response to fasting and exercise (Bastie et 
al. 2005). The metabolic effect of FoxO in the adipose tissue is less well understood. 
A known FoxO modulator Sirtuin 1 mobilizes fat from the white adipocyte tissue in 
mice (Picard et al. 2004). Whether or not FoxO is involved in this process is so far 
unknown. However, the importance of FoxO as a mediator of nutrient responsive gene 
expression is highlighted by a study of Gershman et al. (2007). The authors used the 
model Drosophila and high throughput gene expression pattern profi ling to reveal genes 
regulated by energy level. An astonishing 28% overlap of genes regulated by nutrients 
and FoxO was observed.
The physiological outcome of FoxO activation during energy shortage is to promote 
survival upon starvation, which is achieved by parallel mobilization of energy reserves 
and slowing down the growth rate. The direct involvement of FoxO in starvation 
resistance at the organism level has been studied in Drosophila, which is an organism 
amenable to large scale survival experiments. Surprisingly, Junger et al. (2003) found 
that foxo null adult fl ies were as sensitive to complete lack of nutrients as the controls. 
However, a more refi ned study was conducted by Kramer et al. (2008) who surveyed the 
resistance of foxo null larvae and adults to lack of carbohydrates and proteins separately. 
Indeed, it was found that in a diet consisting solely of carbohydrates the foxo null 
individuals died sooner then the controls. This result suggests a critical role for FoxO 
in the amino acid metabolism. An indirect indication of FoxO’s role in this process has 
come from studies where fl ies have experimentally reduced Insulin signaling activity. 
These fl ies exhibit increased storage of carbohydrates and lipids and are more resistant 
to starvation (Broughton et al. 2005). In addition, Tettweiler et al. (2005) demonstrated 
that protein levels of a FoxO target, 4EBP, are elevated upon complete lack of nutrients 
in Drosophila and this mediates the response to starvation resistance. Similar fi nding 
was done by Teleman et al. (2005) who also discovered that 4ebp null fl ies burn their fat 
reserves faster than control fl ies and are therefore more susceptible to starvation. This 
result suggests that FoxO has an important role in the adipocyte tissue metabolism. Both 
groups, Teleman et al. (2005) and Tettweiler et al. (2005) also showed the involvement 
of FoxO and 4EBP in resistance to oxidative stress. Starvation and oxidative stress 
resistance are thought to have a common genetic background (Wang et al. 2004).
In spite of the numerous studies, the role of FoxO in protection from nutrient 
deprivation is still unclear. Our understanding of this problem is incomplete and will 
require more efforts to gain a clear distinction of the metabolic processes regulated 
by FoxO. One drawback in designing experiments aiming to resolve this question is 
the developmental lethality of FoxO overexpressing flies. Hwangbo et al. (2004) 
and Giannakou et al. (2004) have overcome this problem by utilizing a conditional 
overexpression system which is induced at the adult stage. However, this system has not 
yet been employed in starvation resistance studies.
Life span
The life span of an organism is determined by its ability to maintain physiological 
processes, i.e. genetic stability, telomere shortening, stress resistance and metabolic 
control, decreasing the probability of death (Katic & Kahn 2005). A well known model 
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for life span extension is caloric restriction which is shown to increase organism life 
expectancy in invertebrates and vertebrates including mice (Weindruch & Walford 1982) 
and nonhuman primates (Lane et al. 2000). In addition, caloric restriction (also known 
as dietary restriction) seems to have benefi cial effects in human health although the 
experimental evidence is still, for obvious reasons, very limited (Fontana et al. 2004). 
The mechanisms behind life span increase mediated by caloric restriction are complex 
and not completely understood. This complexity is highlighted by the intriguing fi nding 
of Mair et al. (2005) whose results indicate that calories themselves do not explain the 
longevity of caloric restricted Drosophila, since fl ies kept on a protein diet lived longer 
than fl ies on a carbohydrate diet. Nevertheless, strong evidence points to a role for 
lowered metabolism associated with decreased oxidative stress, which is in agreement 
with the generally accepted concept of free-radical theory of aging (Heilbronn & 
Ravussin 2003, Harman 2006). Caloric restriction is known to modulate multiple 
physiological processes including Insulin signaling through reduced circulating Insulin 
and IGF-1 (Heilbronn & Ravussin 2003). It is therefore not surprising that genetically 
manipulated model organisms with defects in Insulin signaling are long lived (Katic & 
Kahn 2005). In 1997, two groups using the model organism C. elegans demonstrated 
that the life span extension mediated by Insulin signaling was suppressed by loss of 
function of FoxO (Lin et al. 1997, Ogg et al. 1997). This result raised the attention 
towards FoxO as a mediator of long life.
Perhaps the most intriguing property of FoxO biology is its ability to regulate 
organism life span. The underlying mechanisms and its relationship to dietary restriction 
are at the moment under intense investigation. Many of the studies are conducted in the 
fruit fl y which has a plethora of genetic and experimental tools suitable for life span 
experiments. The fi rst demonstration that FoxO directly regulates life span in Drosophila 
came from the pioneering studies of Hwangbo et al (2004) and Giannakou et al. (2004). 
By overexpressing FoxO in the fat body they were able to increase the fl y’s median life 
span by approximately 50%. In addition, Wang et al. (2005) showed that JNK mediated 
life span extension was also mediated through FoxO in fl ies. Taken together, the results 
from model organisms suggested that dietary restricted animals extend their life span by 
lowering the activity of Insulin signaling and consequently, by increasing the activity 
of FoxO. This would further lead to increased overall stress resistance and, as a by-
product, increased longevity. Surprisingly, a direct experiment conducted by Giannakou 
et al. (2008) failed to demonstrate the accuracy of this hypothesis. The authors showed 
that fl ies with a foxo null mutation responded equally as the control fl ies to reduced 
calorie uptake. This result raises the possibility that dietary restriction and Insulin 
signaling mediates longevity through separate routes. More effort and experimental 
scrutiny is needed, however, to unambiguously demonstrate whether this is the case. 
For example, signifi cant emphasis should be put into the composition of the diet used in 
these experiments in order to have comparable results between different labs. It is also 
important to conduct experiments with males and females separately given the difference 
in resource allocation between reproduction and cellular maintenance between sexes 
(a central matter often neglected in the literature). Hence, there is an urgent need for 
general guidelines for performing calorie restriction experiments in Drosophila as well 
as in other model organisms.
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AIMS OF THE STUDY
This work has aimed to deepen the understanding of processes regulated by FoxO tran-
scription factor. The study has involved the upstream regulatory network around FoxO 
as well as its downstream target genes and their function. The study was motivated by 
the following fi ndings: (1) Hyperactivated TOR signaling (as a result of tsc1/2 loss-of-
function) results in a relatively modest tissue overgrowth phenotype compared to the 
pten loss-of-function. This controversy is manifested in the benign and malignant nature 
of the tumours associated with tsc1/2 and pten loss-of-function in humans, respectively. 
(2) dFoxO overexpression in cell culture results in a very high activation of the cAMP 
signaling pathway component adenylate cyclase 76e (ac76e) expression. In addition, a 
more general system biology approach was applied in order to reveal completely new 
aspects of the regulatory network upstream of FoxO. Hence, the specifi c questions ad-
dressed in this study where:
(1) What is the role of FoxO in tissue overgrowth phenotype produced by tsc1 loss-
off-function?
(2) What is the biological relevance of the interaction between dFoxO and Adenylate 
cyclase AC76E in Drosophila? What is the nature of this regulation and what are 
its consequences to fl y development and metabolism?
(3) What are the kinases and phosphatases regulating the transcriptional activity of 
dFoxO?
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MATERIALS AND METHODS
Brief explanations of the essential methods and materials used in this study are presented 
below. For a more detailed description of how a given method or material was applied, 
see the appropriate article.
Cell culture (I, II, III)
The Drosophila cell line used throughout this study was Schneider 2 (S2). The mam-
malian cell lines were mouse hepatoma cells (HEPA1-6) and human embryonic kidney 
cells (HEK293). The S2 cells in all experiments were maintained, treated with dsRNA 
and transfected in M3 (Sigma) supplemented with Insect Medium Supplement (Sigma), 
2% FBS, penicillin and streptomycin. All the transfections were performed with either 
Effectene (Qiagen) or Fugene HD (Roche) transfection reagent according to the manu-
facturer’s protocol. If a metallothionin promoter was utilized to induce protein expres-
sion, 600μM CuSO4 was induced into the medium to initiate the gene expression. Addi-
tives used in cell culture were Human recombinant Insulin (1-10μg/ml) (Sigma), MG-
132 (10-20μM) (Sigma), NH4Cl (20mM), Forskolin (50μM) (Fluka) or IBMX (100μM) 
(Fluka).
Luciferase assay (I, II, III)
Luciferase assays were used mainly for two purposes: (1) to measure the FoxO activ-
ity by utilizing a known FoxO binding sequence upstream of a Luciferase open reading 
frame or (2) to narrow down a promoter region necessary for FoxO transcriptional activ-
ity. Luciferase assays were performed with Promega luciferase assay reagents. Briefl y, 
cells were collected, washed with PBS and lysed in passive lysis buffer (Promega) for 
20-30 minutes at room temperature. After luciferase measurement, the total protein con-
tent was measured from the samples by Bradford reagent (Bio-Rad). The luciferase val-
ues were normalized to the amount of protein in the sample. If necessary, the lysates 
were mixed with 3XSDS loading buffer and analyzed by Western blotting.
RNA interference (II, III)
RNAi assays in S2 cells were performed in the following way. Double stranded RNA 
(dsRNA) molecules were synthesized by in vitro transcription (Ambion) from PCR gen-
erated templates having a T7 promoter attached to both ends. The length of the RNA 
molecules ranged from 200 to 1000 base pairs. The RNA molecules were heated to 95°C 
and slowly cooled down to room temperature to yield correct annealing. The dsRNA 
was diluted to 1μg/μl in dH2O and was used in various concentrations in the cell culture 
medium. Normally, 5μg/ml is suffi cient to knock down the gene of interest. The cells 
were then grown for 2-5 days after which they were processed for downstream applica-
tions. The RNAi experiments in the mammalian cell culture were done by transfecting 
plasmids expressing 29-mer hairpin RNAs (Origene). The knockdown effi ciency was 
estimated with Western blotting with the corresponding antibody, or if such an antibody 
was not available, by quantitative RT-PCR (qPCR).
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Band shift assay (I, III)
Band shift assays were used to assess the binding of recombinant purifi ed dFoxO protein 
to a certain DNA fragment. These fragments were promoter regions containing puta-
tive FoxO recognition elements (FREs). Briefl y, Recombinant dFoxO with 6xHis-Tag 
was recovered from E. coli by Ni-NTA metal chelate affi nity chromatography. Puri-
ty and amount of protein was assessed by SDS-PAGE/ Coomassie Blue staining and 
Bradford assay. Purifi ed dFoxO (100-200nM) was incubated with radioactively labelled 
(32P-dCTP) PCR fragment (80nM) containing the putative FRE for 20 minutes at room 
temperature in reaction conditions described in Coleman and Pugh (1997). The positive 
and negative controls were fragments of the dinr promoter or pBs, respectively. The 
resulting DNA-protein complexes were resolved by native PAGE and were exposed to 
phosphor imager plates (Fuji).
Cyclic AMP measurement (III)
The concentrations of the cAMP in cell culture or tissue samples were measured by 
competitive enzyme immunoassay (Assay Designs). Either cells or tissue samples were 
lysed in 0.1M HCl after which they were measured by the manufacturer’s protocol.
Quantitative RT-PCR (I, II, III)
QPCR was performed using the SYBR green methodology in the ABI Prism 7000 se-
quence detection platform (Applied Biosystems). The results were analyzed using the 
comparative CT method and normalized with Drosophila actin, rp49, tubulin or human 
actin genes. The primers used in the qPCR assays were designed using the Vector NTI 
software (Invitrogen) and were always tested for their specifi city and their amplifi cation 
effi ciency.
High throughput microscopy (II)
The Cellomics Arrayscan 4.5 high throughput microscope was utilized. This system was 
used to measure either the amount of FoxO induced reporter representing its activity or 
the ratio of FoxO protein between nucleus and cytoplasm. The Arrayscan system can 
score the intensity of a fl uorescent protein from thousands of cells or cell compartments 
in a reasonable time window giving the possibility to integrate large material for analy-
sis. It is therefore a very useful tool to measure subtle differences in FoxO localization 
that would have been unnoticed by the traditional “eyespotting” method.
Transgenic animals (III)
The injections of constructs into Drosophila embryos to produce transgenic animals 
were done by the Genetic Services Inc. company (USA).
RNA in situ hybridization (III)
RNA in situ was performed using either Drosophila embryos or larval/adult tissue. Di-
goxigenin-UTP (Roche) labelled sense or anti-sense probes were utilized. In the case of 
embryos the vitelline membrane was removed by brief bleach treatment and the tissue 
was subsequently fi xed. The probes were hybridized to fi xed embryos or adult/larval tis-
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sue for 16h at 55°C. After washing away excess probe the hybridization was visualized 
by alkaline phosphatase conjugated anti-DIG antibody (1:3000, Roche).
Antibodies used for western blotting (II, III)
Antibody Dilution Source
V5 1:5000 Invitrogen
Akt 1:1000 Cell signaling technology
AktSer505 1:1000 Cell signaling technology
α-Tubulin 1:10000 Sigma
HA 1:3000 Covance Research products
FLAG 1:1000 Sigma
dFoxO 1:1000 Puig et al. (2003)
GFP 1:500 Santa Cruz Biotech.
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RESULTS
dFoxO induces the expression of scylla and astray (I)
Previously, genetic evidence has been presented that activity of dFoxO attenuates tissue 
growth when dTOR pathway activity is elevated (Junger et al. 2003). TOR pathway 
activation can be genetically achieved by deleting the tsc1/2 gene, whose function 
is to restrict the pathway upon sub-optimal growth conditions. To understand how 
the observed growth regulation by dFoxO is achieved, the transcriptional profi les of 
tissues with elevated dTOR signaling, as a result of tsc1 null mutation, and S2 cells 
overexpressing dFoxO were compared (Article I, Figure 2). A significant overlap 
was found, indicating that some of the transcriptional response of tsc1 null tissue was 
achieved through the activity of dFoxO. Among the overlapping transcriptional profi les, 
some genes were already shown to be direct dFoxO targets, such as 4ebp and pepck. 
However, many others were still putative targets. Hence, to further demonstrate that 
dFoxO indeed is responsible for the induction of these genes, we decided to further 
characterize dFoxO binding sites from the promoters of two of those genes, astray and 
scylla. Luciferase assays were used to narrow down the region of dFoxO binding, which 
led to the fi nding of putative FREs. Therefore, band shift experiments were performed 
to demonstrate the direct binding of dFoxO to those fragments in vitro (Article I, 
Figure 3). Subsequently, we showed the up-regulation of these genes by dFoxO in vivo 
(Article I, Figure 4). Finally, we demonstrated that similar interaction takes place in the 
mammalian cell culture too; FoxO1 was shown to regulate the expression of several 
mammalian orthologues of the identifi ed dFoxO targets. These included the scylla and 
astray orthologues redd1 and heat shock protein 23 (Article I, Figure 5).
Regulatory network around FoxO (II)
An RNAi screen for kinases and phosphatases regulating dFoxO transcriptional activity 
was performed. All the known and predicted Drosophila kinases (251 proteins) and 
phosphatases (86 proteins) were screened. A primary screen, based on the activity of a 
reporter GFP driven from a dFoxO sensitive promoter (4xFRE promoter), was used to 
narrow down the 337 genes to thirty one putative dFoxO regulators. Importantly, among 
these genes, several of the already known FoxO regulators were present, confi rming 
the validity of the approach. The thirty one candidates were then further characterized 
in a secondary screen for their ability to affect dFoxO transcriptional activity, protein 
abundance and sub-cellular localization. Out of the thirty one candidates, we found 
twenty one regulating at least one of these processes (Table 2 and Article II, Figure 2), 
therefore being confi rmed as dFoxO regulators.
To explore if the network of regulators is conserved in mammals, we decided to 
assess the ability of some of our hits to modulate FoxO transcriptional activity in human 
embryonic fi broblasts (HEK-293) and mouse hepatoma (HEPA1-6) cells. We found 
that eight hits caused a robust increase in FoxO3 transcriptional activity measured by a 
luciferase reporter construct (Article II, Figure 4 and S4). Positive hits in the mammalian 
assay include kinases such as Diacylglycerol kinase δ2 (DGKδ2), Vascular endothelial 
growth factor receptor 1 (FLT-1) and Glycogen synthase kinase-3β. These results 
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Table 2. Hits obtained from the screening.
Kinase/Phosphatase Transcriptional activity Protein stability Localization
CG17026 + - -
CG7177 + + +
CG7597 + + -
Cyclin dependent kinase 9 + + +
Diacylglycerol kinase d - - +
Four wheel drive + - -
Gilgamesh + - -
Greatwall + - +
Ire-1 + + -
Meiotic 41 + + -
Neorospecifi c receptor 
kinase - + -
NinaC + - -
Pdgf- and vdgf-receptor 
related + - -
Protein kinase C + + +
Polo + - +
Protein kinase-like 17e + + -
Protein tyrosine 
phosphatase 69d - - +
Shaggy + - -
Skittles + - -
Strechin-mlck + - -
Tao-1 + - +
+ signifi cant deviation, - no difference
signifi cantly strengthened our analysis and revealed that the regulatory network around 
FoxO is conserved in metazoans.
The most prominent hit in our screen was PKC53E, the Drosophila ortholog of the 
mammalian Protein kinase C alpha (PKCα). The knockout of the function of this gene in 
S2 cells had a very strong effect on dFoxO protein abundance as well as on localization, 
resulting in a reduction of dFoxO protein levels as well as a marked decrease of dFoxO 
in the nucleus. We found that results from PKC53E knockout were specific since 
simultaneous overexpression of PKC53E rescued the dFoxO sub-cellular localization 
phenotype. In addition, overexpression of PKC53E alone resulted in the opposite effect, 
an increase in dFoxO transcriptional activity and nuclear localization. The effect of 
PKC53E knockout was confi rmed with endogenous dFoxO protein. We also explored 
the possibility that the PKC-dFoxO interaction is conserved in mammals. We used RNAi 
to knockout PKCα in HEK293 cells and found a similar effect as with the S2 cells: 
FoxO3 protein abundance was decreased in conjunction with its transcriptional activity 
as measured by a luciferase reporter (Article II, Figure 3 & 4). In summary, these results 
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demonstrate that PKC53E and its closest mammalian orthologue PKCα are regulators 
of FoxO activity.
FoxO is a regulator of cAMP signaling in Drosophila (III)
A microarray study of cells overexpressing constitutively nuclear dFoxOA3 mutant in 
S2 cells revealed adenylate cyclase 76e (ac76e) gene highly activated in this setting 
(Puig et al. 2003). We confi rmed this transcriptional activation by using both qPCR and 
a luciferase based reporter assay. dFoxO was shown to increase the expression of ac76e 
several fold. We then mapped the putative FREs in the ac76e promoter and binding 
of dFoxO to these sequences was assessed by in vitro band shift assays and in vivo by 
chromatin immunoprecipitation (ChIP) (Article III, Figure 1). We cloned the ac76e ORF 
into an expression vector and showed that it encodes a functional protein with adenylate 
cyclase activity (Article III, Figure 2).
To further characterize the functional interaction between dFoxO and AC76E, 
we performed studies in fl ies. The expression pattern of the ac76e gene was analyzed 
by RNA in situ hybridization during embryonic development as well as in the third 
instar larva and adult fl ies. We found that ac76e has a very precise expression pattern 
throughout fl y development. ac76e is strongly expressed in the third instar larva and 
adult corpus allatum (CA), and this expression is dependent on dFoxO since in the dfoxo 
null strain ac76e expression was notably reduced. Further evidence was provided from 
the observation that cellular cAMP levels were reduced in dfoxo null CA (Article III, 
Figure 3). Taken together our results present strong evidence that dFoxO has a role in 
modulating the cAMP signaling by activating the expression of ac76e gene in vivo.
dFoxO regulates Drosophila development, size and starvation 
resistance through Adenylate cyclase 76E (III)
To explore the role of the dFoxO-AC76E interaction in vivo we generated fl ies with a 
UAS-AC76E transgene, which is induced by the targeted spatiotemporal expression of 
Gal4 transcriptional activator. We employed a highly specifi c CA Gal4 line DI-11 to 
drive AC76E overexpression in those cells (Belgacem & Martin 2007). Overexpression 
of AC76E in CA caused retardation in larval development, manifested by delayed pupae 
formation, which was accompanied with reduced adult size (Article III, Figure 4). In 
addition, we sought the possibility that overexpression of AC76E in CA would modulate 
adult starvation resistance. Interestingly, we found that starvation resistance was 
enhanced, but only in females (Article III, Figure 5). Thus our results identify AC76E as 
a key regulator of stress resistance and development.
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DISCUSSION
FoxO is a conditional, Insulin/TOR signaling dependent regulator of 
tissue growth (I)
The idea that FoxO regulates tissue growth conditionally in instances when Insulin sign-
aling activity is low was introduced at 2003 by Junger et al. It was also known for some 
time that TOR signaling induces a negative feedback loop by S6K mediated phosphor-
ylation of the Insulin receptor substrate (IRS), thereby shutting down the Insulin signal-
ing pathway (Haruta et al. 2000, Manning 2004). Presumably, this mechanism would 
ensure that cells do not over-proliferate upon conditions of abundant nutrient/growth 
factors. We have shown that elevation of TOR signaling leads to activation of FoxO. 
This result is in favour of the idea that FoxO is part of the negative feedback regulation 
induced by attenuated TOR signaling. Whether this interaction is through a direct phos-
phorylation of FoxO by TOR/S6K or through PI3K/Akt inhibition is not known (Figure 
1). Evidence supporting the latter can be found from the literature; Manning et al. (2005) 
have shown that tsc2+/- mice develop liver hemangiomas with nuclear FoxO1. However, 
the liver hemangiomas with double heterozygote tsc2+/- pten+/- mice were more severe 
and showed predominantly cytoplasmic FoxO1 localization, suggesting that regulation 
of FoxO1 in this setting goes through PI3K/Akt. This observation together with the 
fi nding that mouse embryonic fi broblasts (MEFs) lacking tsc1/2 gene function exhibit 
strong attenuation of Akt and loss of FoxO regulation, strongly supports that elevated 
TOR signaling leads to down-regulation of Insulin signaling in these cells (Manning et 
al. 2005). 
In this study, we tried to solve the question of how dFoxO activity is modulated by 
dTOR signaling but unfortunately the question remains unanswered. Our experiments 
failed to demonstrate the interplay between activated dTOR and Insulin signaling lead-
ing to regulation of dFoxO. For example, in S2 cells down-regulation of dTOR activ-
ity through RNAi mediated knockout of dTOR or dRaptor did not signifi cantly change 
dFoxO localization (J. Mattila, unpublished observation). This result suggests that dTOR 
signaling affects dFoxO independently of the IRS mediated negative feedback loop. 
Evidence supporting this view has been presented by Luong et al. (2006) who showed 
that the Insulin insensitive dFoxOA3 mutant activity is dependent on dTOR signaling in 
vivo. It is therefore possible that dTOR modulates the activity of dFoxO independent of 
PI3K/Akt signaling. Interestingly, Patel & Tamanoi (2006) demonstrated that increased 
dTOR signaling sensitizes the fl ies to oxidative and nutritional stress. This is in complete 
contrast to the idea that dFoxO is activated through dTOR since in all the reported cases 
augmented FoxO activity leads to elevated stress resistance. Further research is needed 
to illustrate the regulatory mechanisms behind this complex network.
Regardless of the mechanism, our results clearly demonstrate that FoxO has a role 
in restricting overgrowth upon TOR hyperactivation. In addition, we showed that FoxO 
induces the expression of scylla and its mammalian homologue redd1. This gene is 
known for its negative impact on TOR signaling in mammals and in Drosophila (Reil-
ing & Hafen 2004, Corradetti et al. 2005). It is therefore possible that FoxO plays an 
important role as a transducer of the negative feedback loop on TOR signaling ensuring 
ordered growth control upon abundant growth factors. The function of FoxO in this con-
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text could also provide an explanation for the benign nature of the tumours in the human 
genetic disorder called tuberous sclerosis (Curatolo et al. 2008).
FoxO activity is modulated by an elaborate regulatory network (II)
The data shown in the original article II demonstrate that FoxO activity is under the 
control of several signaling pathways which balance its activity to meet the prevail-
ing environmental conditions in terms of nutrient availability and stress. Several known 
dFoxO regulators were found in our screen and twenty one new dFoxO regulators were 
identifi ed including nineteen kinases and two phosphatases. According to the Drosophila 
gene annotation (Flybase), among the hits were three inositol-lipid metabolism associ-
ated genes (cg17026, fwd, sktl), two cyclin dependent kinase genes (cg7597, cdk9), two 
PKC signaling associated genes (dgkd, pkc53e), two WNT-signaling associated genes 
(gish, sgg), three cell cycle associated genes (gwl, mei-41, polo) and four transmembrane 
receptor genes (nrk, pvr, ptp69d, tao-1).  Based on our screening assays, the dFoxO reg-
ulators were classifi ed upon their ability to modulate cytoplasmic localization, protein 
stability or transcriptional activity (Table 2). Several dFoxO regulators were identifi ed 
with high probability. This statement is based on the scrutiny of the screen. In total, the 
hits were analysed with four different assays in the Drosophila S2 cells. In addition, an 
accompanying survey of the mammalian orthologues to regulate FoxO3 transcriptional 
activity was performed. Indeed, nine out of the ten tested orthologues were found to 
regulate FoxO3 activity in mammalian cell culture.
Among the hits, several interesting candidates exist. These include, for example, 
PKC, GSK-3β (sgg) and POLO. GSK-3β and POLO are implicated in glucose metabo-
lism and cell cycle regulation, respectively, and PKC isoforms are well known for their 
role in the Insulin signaling pathway (Sampson & Cooper 2006). Additionally, a PKC 
upstream activating kinase, DGKδ was identifi ed from the screen as a FoxO regulator. 
This fi nding further strengthens the idea that PKC is an important FoxO activity modula-
tor. Interestingly, in our experimental conditions PKC did not modulate Akt phosphor-
ylation, implying that the interaction between FoxO and PKC is independent of Insulin 
signaling. Co-immunoprecipitation experiments with overexpressed PKC and FoxO in 
Drosophila S2 cells revealed that FoxO was pulled down with a truncated PKC protein, 
lacking the kinase domain, but not with the full length protein (J. Mattila, unpublished 
observation). The signifi cance of this observation was left unresolved and hence, future 
studies are needed to show the association between these proteins. Based on its role 
as a negative feedback regulator of the Insulin signaling (Leitges et al. 2002), it is not 
surprising that PKC was found to regulate FoxO as well. This could be seen as an ad-
ditional level of regulation, ensuring rapid activation of FoxO and transcription. In order 
to discuss the nature of this regulation in vivo, some key questions are to be solved. Spe-
cifi cally, (1) what are the tissues and developmental processes that the regulation takes 
place and (2) how is the interaction induced? The utilization of the powerful genetic 
tools of Drosophila melanogaster would certainly be of great help in addressing these 
questions.
The strongest supporting evidence in the literature is provided for GSK-3β as being 
an important FoxO regulator. Initially, GSK-3β was identifi ed as the kinase inhibiting 
the Glycogen synthase, the rate limiting enzyme of glycogen deposition. On the other 
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hand, GSK-3β is a known tumour suppressor whose inaccurate functioning is promot-
ing many cancer types (Luo 2009). In addition, it is known that one of the key events 
in promoting cell survival is the inhibitory phosphorylation of GSK-3β by Akt (Cross 
et al. 1995, Grimes & Jope 2001). Finally, inhibition of GSK-3β has been shown to at-
tenuate the expression of pepck and g6pase which are known FoxO targets, providing 
a direct link between GSK-3β and FoxO regulated gene expression (Lochhead et al. 
2001). Taken together, these results strongly suggest that GSK-3β exerts at least some of 
its functions through FoxO.
In spite of the apparent ability of our screen to identify enzymes regulating FoxO 
activity, the results presented should be considered with some caution. The identifi ed 
twenty one genes represent a list of putative dFoxO activity modulators and should not 
be considered as a comprehensive set of kinases and phosphatases regulating dFoxO 
activity. Moreover, it is possible that some of the hits represent false positives. This 
assumption is based on the limitations of the screening assay that was used. Primarily, 
FoxO activity assays utilized in this screen were based on transcription/translation of 
the reporter proteins luciferase and GFP. In any genome scale RNAi screen a number of 
targets are general regulators of these processes. Hence, these factors are picked up by 
the assay unless a suitable transcription/translation normalization procedure is used. In 
our primary and secondary screen the normalization was achieved by expressing an RFP 
plasmid under a constitutively active promoter and by measuring the sample overall pro-
tein concentration by the Bradford reagent, respectively. These measures were then used 
to normalize the assay output. However, the effi ciency of the normalization procedures 
to completely exclude false positives, i.e. general regulators of protein biosynthesis, is 
uncertain and it is still possible that false positives were picked. 
A second uncertainty of the screen comes from the fact that no inhibitors of FoxO 
activity were found. This observation could also refl ect the utilization of the luciferase 
assay. Since overexpression of FoxO results into a regulatory loop fi nally shutting down 
the translational and/or transcriptional machinery, either directly through the induction 
of 4EBP or indirectly by sequestering general transcriptional/translational factors, it is 
possible that increase in its activity could not be recorded in a translation based assay 
(see fi gure S1A in the original article II; RFP intensity is greatly enhanced upon dFoxO 
RNAi). An attempt to overcome this problem was the utilization of the localization assay 
which is not hampered by the limitations described above. However, no new inhibitors 
(besides the already known Akt and PDK1) were found based on this assay either.
Finally, it is important to point out that the interaction per se does not yet imply a 
biological function in vivo. Additionally, these results could not distinguish between 
direct and indirect regulation. More experiments, such as co-immunoprecipitation and 
kinase assays are necessary to reveal these mechanisms. Further, to demonstrate a bio-
logically meaningful interaction, in vivo studies are required. Hence, our list of FoxO 
regulators provides material for future studies, and hopefully aids in fi nding some still 
missing pieces in the complex puzzle of FoxO signal transduction.
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Systemic regulation of development and size by dFoxO through AC76E 
(III)
The cAMP pathway components are conserved in Drosophila. In the fl y genome there 
are fi ve transmembrane AC genes related to the nine mammalian AC isoforms. In addi-
tion, a group of more distantly related AC isoforms, known as the DACX family, exists 
(Cann et al. 2000). At present, little is known about the AC isoforms in Drosophila. 
Few studies addressed their differential expression throughout embryonic development 
but their role in vivo or how their expression is regulated is not known. However, the 
activity of the pathway has been shown to be essential for the fl y longevity and stress 
resistance. Tong et al. (2007) have reported that core components of the cAMP signal-
ing pathway, adenylate cyclase rutabaga, cAMP phosphodiesterase dunce and pka, are 
transducing the Neurofi bromatosis-1 dependent resistance to ROS and life span exten-
sion. It was further demonstrated that feeding fl ies with cAMP analogs dibutyryl-cAMP 
and 8-bromo-cAMP increased life span (Tong et al. 2007). Similarly, Wang et al. (2008) 
have shown that the Drosophila CREB coactivator TORC promotes resistance to ROS 
and starvation. These results raise the possibility that an analogous role of cAMP in 
regulating fasting metabolism is acting in Drosophila.
The data presented in our original article III outlines an important role for FoxO 
as a mediator of cAMP signaling. Our results indicate that dFoxO increases the cellular 
cAMP levels through its direct induction of ac76e expression. Flies with a dfoxo null 
mutation exhibited reduced ac76e expression as well as reduced cAMP levels. In addi-
tion, overexpression of the AC76E in a subset of its natural expression pattern, in the 
larval and adult CA, resulted in lengthening of the larval developmental time, dwarf fl ies 
and an increase in the female starvation resistance. Although we have not yet been able 
to show a mechanistic explanation for this, a strong downstream candidate for regulat-
ing the observed phenotype is juvenile hormone (JH). Several pieces of evidence are 
in favour of this hypothesis: (1) the observed phenotype, i.e. long larval developmental 
time and dwarf fl ies, are suggestive of defective endocrine signaling such as ecdysone 
or JH, which controls the larval moulting and growth (De Loof, 2008), (2) the regula-
tion is taking place in CA which is the source of JH synthesis, (3) an increase of cAMP 
synthesis in the ring gland has been shown to decrease the JH synthesis/release (Richard 
et al. 1990), (4) fl ies with a null mutation in dinr are dwarf and defective in JH synthesis 
(Tatar et al. 2001), (5) targeted knockout of dinr in the CA results in dwarf fl ies sug-
gesting that dFoxO is involved in emitting a signal from this tissue which systemically 
regulates growth (Belgacem & Martin 2007). Finally, it has to be mentioned that the 
observed phenotype, delayed development and small size, is analogous to the outcome 
of larval starvation. This implies that the ac76e expression through FoxO is regulated by 
nutrient availability.
In summary, our results demonstrate that AC76E is regulating systemically the tim-
ing of pupae formation. In addition, our results suggest that dFoxO is involved in this 
process by controlling the expression of ac76e in the CA. It was previously shown that 
dFoxO controls the synthesis of DILP2 (Hwangbo et al. 2004, Wang et al. 2005). These 
results are in favour of a mechanism where upon insuffi cient larval growing conditions 
dFoxO inhibits the Insulin signaling pathway by reducing DILP2 production in the IPCs, 
which is then followed by growth attenuation in the peripheral tissues. Simultaneously, 
reduced Insulin signaling results in dFoxO activation in the CA. This is then followed 
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by the activation of the cAMP pathway and its downstream systemic signal ensuring 
that moulting is not initiated prematurely (Figure 5). Taken together, in addition to its 
known role as a cell autonomous cell cycle brake, dFoxO seems to have a critical role in 
regulating the developmental growth non-cell autonomously.
Our study has three main limitations: First, the lack of an ac76e null mutant 
hampered our genetic studies where all results have been obtained by overexpression of 
the AC76E. We used strains with constructs driving RNAi against AC76E but the reduc-
tion in mRNA expression was not enough to fully eliminate its activity. Second, the lack 
of a reliable AC76E antibody prevented us from fully characterizing its function. We 
produced antibodies against AC76E but their specifi city was not suffi cient to be used in 
further studies. And fi nally, the lack of proper genetic interaction data in vivo prevented 
us to make a defi nitive conclusion about the role of dFoxO in this context. This was due 
to the early lethality of dFoxO overexpression in the CA. Therefore, at present the in 
vivo data relies solely on overexpression of the AC76E. These defi ciencies need to be 
taken into account when interpreting the dFoxO-AC76E function.
Figure 5.  A model describing the role of dFoxO in systemic growth regulation in 
Drosophila.
Nutrients, i.e. sugars and amino acids, trigger Drosophila Insulin-like peptide (DILP) synthesis 
and release from Insulin producing cells (IPC). DILPs have auto- and endocrine functions in 
IPC and corpus allatum (CA) cells, respectively. Under stress or nutrient depletion, dFoxO 
inhibits the insulin signaling pathway by reducing DILP2 production in the IPCs, which is then 
followed by growth attenuation in the peripheral tissues (Hwangbo et al. 2004, Giannakou et al. 
2004). Simultaneously, dFoxO activates cAMP production in CA which causes a reduction in JH 
synthesis, ensuring that moulting is not initiated prematurely (predicted from our results).
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Conclusions
CONCLUSIONS
In summary, in this study we have provided valuable information that helps to understand 
better the role of FoxO in regulating critical processes like cell and organism growth and 
stress resistance. In the original articles I and III special emphasis was directed to the 
regulation of growth through dFoxO. We showed that dFoxO regulates the expression of 
scylla and ac76e, which presumably both have a role in growth control, although in dif-
ferent hierarchical levels. Whereas scylla has a role in the cell autonomous growth in the 
peripheral tissues by regulating the activity of the TOR signaling, ac76e is systemically 
orchestrating the developmental growth and timing of pupariation of the whole animal. 
These results provide supporting information in placing FoxO among the major meta-
zoan growth regulators. In addition to downstream targets, several modulators of FoxO 
activity were identifi ed in the original article II, highlighting the importance and range of 
biological functions in which this transcriptional regulator is participating. The obtained 
catalog of interactions will provide important information for researchers in their future 
attempts to reveal more insights into FoxO regulated processes.
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FUTURE PROSPECTS
The results presented in this study raise several interesting questions and suggest fi elds 
for future studies. Specifi cally, the negative feedback regulation of Insulin and TOR 
signaling through FoxO is far from being completely understood. Given the important 
role this signaling network has in the pathogenesis of a variety of human carcinomas, 
the precise knowledge of how this regulatory loop behaves is of outmost importance. 
Advances in the understanding of this process could have important implications in the 
development and application of anti-tumour drugs. However, the unfolding of this com-
plex network of interactions requires the combination of bioinformatics and experimen-
tal work. It is noteworthy that the mechanisms within this signaling vary between cell 
types and experimental conditions, making the task enormously challenging. Therefore, 
the integration of all available data to give a clear overall view requires the application 
of sophisticated systems biology tools. We assume the development of new prediction 
algorithms in the future years will revolutionize the experimental approaches used for 
signal transduction studies and will thus bring us closer to solving the nature of these 
interactions.
Currently the data presented in the original article II is mostly a database of interac-
tions. To reveal the function of these regulatory interactions and their biological signifi -
cances, individual characterizations are needed. In addition, given the number of parallel 
regulatory pathways, a remaining challenge is to understand how FoxO activity is bal-
anced. We are confi dent that this set of data can provide valuable information to other 
researchers to open the way for a more detailed characterization of these interactions. 
The accredited role of AC76E in the development and growth of the Drosophila lar-
vae need further investigation to elucidate a more profound understanding of the biologi-
cal role of the dFoxO-AC76E interaction. Furthermore, the observed phenotype requires 
a mechanistic explanation. The nature of the signal emanating from the CA has not yet 
been solved. As mentioned above, the obvious candidate for such a signal is the juvenile 
hormone. However, this hypothesis has not been directly demonstrated. In addition, the 
specifi c outcome of this systemic signal is yet to be described. For example, what are the 
downstream signaling events in the peripheral tissues and how do they contribute to the 
tissue growth?
Future Prospects
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